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Abstract 
Grape-derived products are high in polyphenols and are known to have anti-oxidant and anti-
inflammatory effects. In vivo studies in the context of muscle injury-induced inflammation 
have proven grape seed-derived proanthocyanidin oligomers (PCO) to benefit recovery by 
modulation of neutrophil infiltration into damaged tissue, thereby reducing secondary 
damage. Also, in these models, PCO have been shown to facilitate an early anti-inflammatory 
macrophage phenotype shift, which resulted in faster resolution of inflammation and 
shortened recovery time. However, these results have not been investigated in a human model 
and the specific molecular targets of PCO is not clear. 
This study therefore aimed to investigate potential molecular targets of PCO in a normally 
healthy population.  In addition, given anecdotal concern about consumer safety, a secondary 
aim was to investigate haematological effects of short-term PCO supplementation in humans. 
A limited haematology assessment was included to address these concerns. 
Eighteen normally healthy volunteers between the ages of 18-25 years old (13 female and 5 
male) were subjected to daily oral supplementation with 140mg of PCO for a 2-week period. 
Blood samples were taken at baseline (day 0), as well as on days 7 and 14. Day 0 and 14 
samples were comprehensively analysed for in vitro neutrophil chemokinetic capacity 
towards a chemotaxin (fMLP) using live cell tracking software, as well as neutrophil 
expression levels of adhesion molecules (ICAM-1, VCAM-1 and CD66b) by flow cytometry 
and cell polarisation factors (ROCK, PI3K) using immunohistochemistry. Macrophage 
expression of markers indicative of different phenotypes were assessed using flow cytometry. 
In addition, day 7 samples were assessed for PCO-induced effects on general haematology 
and hemostasis. 
No adverse effects of PCO was evident. A novel neutrophil migration assay was developed to 
allow immunohistochemistry staining on chemokinetic neutrophils, allowing assessment of 
molecular role players involved in chemokinesis and actual movement capacity on the same 
cells. Although PCO supplementation had no evident effect on neutrophil chemokinesis or 
adhesion molecule expression, the increase in ROCK co-localisation with PI3K under 
stimulated conditions was prevented, while ROCK expression itself tended to be decreased. 
Macrophage phenotype markers CD274 and MPO – both indicative of a pro-inflammatory 
M1 phenotype – was normalised after PCO treatment.   
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We conclude that the PCO product employed in the current study, was safe for consumption. 
Furthermore, data indicates that neutrophil chemokinetic capacity may be optimised by PCO 
via modulation of the ROCK-PI3K-PTEN system, which results in better front-rear 
synchronisation of cell polarisation and thus movement. Finally, data confirms earlier reports 
in rodents, of a direct effect on macrophages to achieve a relatively anti-inflammatory 
phenotype predominance.  
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Uittreksel 
Produkte afgelei van druiwe bevat hoë konsentrasies polifenole en is bekend vir hul anti-
oksidant- en anti-inflammatoriese effekte. In vivo-studies oor spierbeskadiging en verwante 
inflammasie, het bewys dat druif-verwante polifenole (PCO) herstel stimuleer deurdat dit 
infiltrasie van neutrofiele na die beseerde weefsel beperk, wat sekondêre skade verminder. 
Hierdie modelle het ook gewys dat PCO ‘n vroëë anti-inflamatoriese fenotipeverskuiwing in 
makrofage bewerkstelling, wat lei tot ‘n vinniger afname in inflammasie en ‘n verkorte 
hersteltyd. Hierdie effekte is egter nog nie voldoende in mensmodelle nagevors nie en die 
spesifieke molekulêre teikens is onbekend. 
Hierdie studie het gepoog om die teikens van PCO in ‘n gesonde populasie te ondersoek. 
Gegewe berigte van gebruikerskommer rakende veiligheid, was ‘n verdere doel om die effek 
van korttermyn supplementasie met PCO op die algemene hemotologie and hemostase te 
ondersoek. 
Agtien gesonde vrywilligers, tussen die ouderdomme van 18-25 jaar (13 vroulik en 5 
manlik), is onderwerp aan ‘n daaglikse mondelinge aanvulling van 140mg PCO oor ‘n 
tydperk van twee weke. Bloedmonsters is geneem voor supplementasie (dag 0), asook na 7 en 
14 dae van aanvullling. Dag 0 en 14 monsters is deeglik ondersoek vir in vitro neutrofiel 
chemokinetiese bewegingskapasiteit in die rigting van ‘n chemotaksin (fMLP) deur van 
lewendesel-mikroskopie asook neutrofiel uitdrukkingsvlakke van adhesiemolekule (ICAM-1, 
VCAM-1 en CD66b), deur vloeisitometrie en selpolarisasiefaktore (ROCK, PI3K) met 
immunohistochemie gebruik te maak. Makrofaaguitdrukking van merkers wat verskilledne 
fenotipes aandui is met vloeisitometrie bepaal. Dag 7 monsters is ontleed vir PCO-verwante 
effekte op algemene hemotologie en hemostatse-aanwysers. 
Geen newe-effekte van PCO inname was waarneembaar nie. ‘n Nuwe neutrofielmigrasietoets 
is ontwikkel om immunohistochemiese ondersoeke op migrerende neutrofiele te kon uitvoer, 
om die bewegingskapasiteit en molekulêre rolspelers in dieselfde selle te assesseer. Alhoewel 
PCO aanvullings geen sigbare effek op neutrofielbeweging of die uitdrukking van 
adhesiemolekule gehad het nie, was ROCK-uitdrukking op neutrofiele laer, terwyl die 
verhoodge gesamentlike uitdrukking van ROCK met PI3K, wat gepaard gaan met stimulasie, 
betekenisvol ge-inhibeer is. Die makrofaag merkers CD274 en MPO, beide aanwysers van 
die pro-inflammatoriese M1 fenotipe, het na PCO aanvulling genormaliseer.  
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Die gevolgtrekking is dat die PCO-produk veilig is vir gebruikers. Verder dui data aan dat 
neutrofiel-chemotaktiese kapasiteit ge-optimaliseer word deur PCO, deurdat dit die ROCK-
PI3K-PTEN sisteem moduleer, om sodoende beter voorpunt-agterpuntsinchronisasie van 
selpolarisasie en dus beweging, teweeg te bring. Die data verkry in hierdie studie onderskraag 
vroëëre eksperimentele dat verkry in knaagdiere, van ‘n direkte effect van PCO op makrofage 
sodat die anti-inflammatoriese fenotipe oorheers.  
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1.  CHAPTER 1: INTRODUCTION 
 
Due to advances in medicine in general, the world population are increasing in age as average 
lifespan is increasing (Naghavi et al., 2015). Advanced age is characterised by a relatively 
more pro-inflammatory profile and increased oxidative stress. Furthermore, modern society is 
increasingly burdened by inflammation-related illnesses. Inflammation is now a commonly 
accepted aetiological factor in lifestyle diseases such as cardiovascular disease, type II 
diabetes and depression, as well as in cancer. In terms of the inflammatory and oxidative 
stress profiles of these diseases, they can all be classified as manifestations of “accelerated 
ageing”.  It is thus imperative to find solutions to the increasing burden on the health sector in 
this context. 
Various therapeutic targets have been researched which may assist in the elevation of chronic 
inflammatory diseases. There are many non-steroidal as well as natural products that assist in 
the clearance of secondary damage caused by inflammation. New products are constantly 
being pushed onto the market without being thoroughly tested and scientists are currently 
under immense pressure to try and keep up. Also, natural products are becoming an 
extremely popular choice in mediating chronic inflammatory diseases. Natural products such 
as polyphenols have showen potential in both an anti-inflammatory as well as anti-oxidative 
capacity. The issue however, is that natural products are not as thoroughly researched as 
pharmaceutical products and this could be compromising to a person’s health if products are 
not properly understood.  
In order to evaluate the potential of experimental treatment or supplements on these systems, 
it is necessary to understand the processes and mechanisms at play. For example, 
inflammation and oxidative stress are two intricately interlinked processes (Petersen et al., 
2016). Although oxidative stress is not a topic of this thesis, it is important to note that 
inflammation – and particularly the neutrophil phase – is known to result in oxidative stress-
related secondary damage to healthy tissue, via oxygen radical release by neutrophils during 
oxidative burst (Tidball, 2005). Also, particularly in aged individuals, directional inaccuracy 
of movement of neutrophils toward a chemotactic signal (also termed chemokinesis), have 
been implicated in further tissue damage (Sapey et al., 2014). 
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Conversely, anti-oxidant treatment has been associated with a more desirable inflammatory 
profile in various models (Petersen et al., 2016).  In addition, our group have recently shown 
anti-oxidant treatment to improve neutrophil directional accuracy (Petersen and Smith, 2016).  
Briefly, human donor blood was treated with a grape seed-derived polyphenol in vitro, before 
assessments were made. Thus, the purpose of this thesis was to expand on these results by 
firstly performing an in vivo supplementation study and secondly to include investigation of 
parameters which may influence directional accuracy of neutrophil chemokinesis. This 
includes brief investigation of potential contributions by macrophages, which is known to 
secrete a number of chemokines and cytokines affecting the inflammatory process (Smith et 
al., 2008), as they are known to co-exist with neutrophils as major role players during 
inflammation. 
In the next chapter, and overview of the phagocytic immune cells and mechanisms at play 
during chemokinesis, will be discussed. In addition, an overview of the literature related to 
plant-derived products in this context, will be provided.    
 
  
  
Stellenbosch University  https://scholar.sun.ac.za
 3 
2.  CHAPTER 2: LITERATURE REVIEW 
 
2.1 Introduction 
 
The immune response, arguably most important to both innate and adaptive immunity, is 
inflammation. The main purpose of inflammation is to send phagocytes to sites of infection 
or injury. At the sites of infection, phagocytes may isolate, destroy or disable the invaders; 
remove debris; and prepare the healing and repair process (Sherwood, 2015). The 
inflammatory process follows a similar trend regardless of the trigger (bacterial, chemical 
injury or mechanical trauma). The acute inflammatory response lasts for a short duration and 
is characterised by the accumulation of leukocytes, cytokines, neutrophil infiltration and fluid 
exudation (Sherwood et al., 2004). When this initial inflammatory response persists for 
longer periods, it results in chronic inflammation (either low grade or severe) states. Chronic 
low grade inflammation leads to cumulative oxidative stress and secondary damage to 
healthy tissue and has been implicated in various modern diseases of lifestyle (Sherwood, 
2015). 
The process of inflammation is initiated through the first event of vasodilation, which leads to 
a pyrogenic reaction and results in the site of injury becoming red and warm. The small blood 
vessels with thin vascular endothelium normally permit free exchange of water and small 
molecules between blood and tissue spaces; but limit the passage of plasma proteins. 
However, after injury, the permeability of the injured area increases and consequently allows 
plasma proteins, leukocytes and more fluid from the blood to secrete into the tissue spaces 
(Sherwood et al., 2004) .Leukocytes, especially neutrophils and monocytes, migrate out of 
the blood vessels and accumulate in vast numbers at the site of injury. Neutrophils 
predominate the first 6 to 24 hours in acute inflammation and are later replaced by monocyte 
migration within 24 - 48 hours. However, the patterns of leukocytes exudates differ 
depending on various factors of initiation (viral or bacterial infection or hypersensitivity 
(Sherwood et al., 2004). Resident macrophages are converted monocytes that may exhibit 
two distinct phenotypes. The M1/M2 phenotypes describe the two major and opposing 
behaviours of macrophages. The M1 phenotype inhibits cell proliferation and causes tissue 
damage while the M2 phenotype promotes cell proliferation and tissue repair (Mills, 2012). 
Cellular debris from the damaged tissue is removed by the infiltrating neutrophils before 
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satellite cells proliferate to replace the previously damaged and phagocytized tissue. In 
addition to phagocytosis, neutrophil invasion and activation can also lead to the release of 
reactive oxygen species (ROS) and proteases which potentially cause further injury to the 
affected site (Toumi et al., 2003). Figure 2.1 illustrates the proposed mechanism of the 
relation between inflammatory response and the further tissue damage caused by neutrophils. 
 
 
 
Figure 2.1: Proposed mechanism of the relation between the inflammatory response and further tissue 
damage. Neutrophils may promote further damage through the release of oxygen free radicals and lysosomal 
proteases and elastase (Toumi et al., 2003). 
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2.2 Neutrophils 
 
2.2.1 Role in inflammation  
 
Neutrophils protect the body against any type of infection whether bacteria or fungal, and are 
the body’s first line of defence. Once activated, they move swiftly to the site of infection or 
inflammation and therefore have been identified as key players during the immune response 
(Smith et al., 2008).  
Phagocytosis is the mechanism used by neutrophils (and other phagocytes) to ingest foreign 
invaders and/or cellular debris at the site of infection/injury (Gambardella et al., 2013). 
During the process of phagocytosis, neutrophils generate ROS that is involved in 
degranulation and subsequent release of proteases and inflammatory mediators. Although this 
process is a necessary step that helps to clear the site from pathogens and cellular debris, it 
may also results in secondary damage to previously healthy tissue. In fact, up to 80% of total 
tissue damage after infection/injury can be ascribed to neutrophil secretory products (Tidball, 
2005).  Furthermore, unused or excess neutrophils undergo apoptosis and have to be removed 
by pro-inflammatory macrophages via phagocytosis. Only when this step has been 
completed, can resolution of inflammation commence, via M2 macrophage action (Järvinen 
et al., 2005).  
Given the potential for neutrophils to exacerbate damage, and the commonly known 
phenomenon of maximal response of the immune system, it may be possible to limit the 
capacity of neutrophils to cause secondary damage, without compromising the effectiveness 
of the response. Specifically, the neutrophil response can be “optimised” in terms of its 
efficacy so that fewer cells would be required for any given stimulus. One way in which this 
may be achieved, is via the optimisation of neutrophil migration through tissue in terms of 
speed and/or directional accuracy. In the next sections, I will provide an overview of the 
mechanisms used for migration, before discussing potential intervention in this context. 
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2.2.2 Mechanisms of neutrophil migration 
 
Neutrophils are produced in the bone marrow and do not have a particularly long lifespan (<1 
day), but when needed they can move out of the bone marrow quickly and in great numbers 
(Smith et al., 2008), (Gambardella et al., 2013);. Mature neutrophils that are found in the 
bloodstream can form connections with the blood vessel wall. They do so by interacting with 
2 different classes of receptors as well as integrins and selectins (Gambardella et al., 2013), 
(Hillgruber et al., 2015). The process of extravasation of neutrophils entails slowing down, 
rolling along the blood vessel wall, attaching to endothelial cells and then transendothelial 
migration into tissue, which is directed by chemotactic signals released from the site of 
infection or damage (Smith et al., 2008), (Gambardella et al., 2013), (Hillgruber et al., 2015). 
For neutrophils to become adherent upon activation, their integrins (mostly β2) need to bind 
to the proteins within the extracellular matrix (ECM) which in turn connects them to the actin 
cytoskeleton (Gambardella et al., 2013). β2 integrin-deficient neutrophils do not migrate 
towards the chemoattractant and therefore cannot form an attachment on the ECM 
(Gambardella et al., 2013). 
 
2.2.3 Neutrophil adhesion molecules 
 
The movement of immune cells from vascular endothelium into the intravascular space 
occurs via cellular adhesion molecules that guide the process of recruitment, adhesion and 
translocation of these immune cells (Smith et al., 2008). To ensure increased leukocyte 
numbers from vascular sites to the site of inflammation, the endothelium needs to be 
activated by pro-inflammatory cytokines, namely tumor necrosis factor-alpha (TNF-α) or 
interferon-gamma (INF-γ) (Smith et al., 2008), (Kuntz et al., 2014). Various cellular 
adhesion molecules are also expressed over different periods to facilitate this process. 
Abnormalities in the regulation of some of these molecules have been linked to various 
pathophysiological conditions, such as chronic inflammation, cancer and atherosclerosis 
(Kuntz et al., 2014). For example, relevant to our topic of migration, cellular adhesion 
molecule mal-adaptation was shown to contribute to endothelial irregularities in 
atherosclerosis, an outcome which will no doubt also affect leukocyte migration across 
endothelial cells (Kusters et al., 2012).  
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E-selectin is also an adhesion marker, which is responsible for the initial contact between 
leukocytes and the vascular endothelium. Specifically, E-selectin allows for the first 
attachment of leukocytes to the vascular endothelium and this is referred to as tethering 
(Kuntz et al., 2014). The two other adhesion molecules of interest to the present review are 
intracellular adhesion molecule 1 (ICAM-1) and vascular adhesion molecule 1 (VCAM-1) 
and are known to be responsible for the strong adhesion and transmigration of immune cells 
into the intravascular space (Kuntz et al., 2014). ICAM-1 and VCAM-1 are not only 
expressed on cell surfaces, but also in plasma in a soluble form (Smith et al., 2008). CD66B 
is one of four granulocyte specific activation antigens that form part of the Cd66 family 
(Jensen et al., 2012), (Schmidt et al., 2012), (Zhou et al., 2012). Upon stimulation, CD66B 
expression on neutrophils becomes upregulated and is known to play a pivotal role in 
adhesion and activation of these cells (Jensen et al., 2012), (Schmidt et al., 2012), (Zhou et 
al., 2012). A study by Kuntz et al., (2014) involving the use of two types of curly kale 
preparations on human umbilical vein endothelial cells (HUVECs) reported a reduction of 
both ICAM-1 (74.6 ± 10.2% and 76.6 ± 7.9%) and VCAM-1 (35.0 ± 14% and 81.66 ± 7.9%) 
mRNA levels in HUVECs stimulated by both types of curly kale preparations. They 
concluded that curly kale extracts play a particular role in the modulation of TNF-α 
stimulated neutrophil adhesion and resulted in the reduction of adherent neutrophils (Kuntz et 
al., 2014).  
It is vital that neutrophils are motile and able to assist in the inflammatory process. 
Atherosclerosis-associated inflammation was reported to be mediated by a rise in the 
concentration of soluble adhesion molecules (Roberts et al., 2006); (Petridou et al., 2007). 
Interestingly, people suffering from chronic diseases such as diabetes, and have taken up 
regular exercise as a form of therapy were reported to show a decrease in soluble ICAM-1 
level, which may contribute to the normalisation of serum lipid and insulin levels as well as a 
reduction in oxidative stress level observed in the subjects (Roberts et al., 2006). This result 
indicates how intervention in this context may have significant clinical effectiveness. 
Gorina et al., (2014) determined how selectin-independent neutrophil interact with the blood 
brain barrier (BBB) and focused on the role of β2 integrins and their endothelial ligands 
ICAM-1, ICAM-2 and junctional adhesion molecule-A (JAM-A). Neutrophil crawling was 
only seen to be inhibited in the absence of the combined ICAM-1 and ICAM-2 or when all β2 
integrins were absent (Gorina et al., 2014). VCAM1 played no role in the interaction between 
neutrophil and the inflamed BBB (Gorina et al., 2014). Although this data was generated in a 
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model specific for the BBB, it highlights the importance of assessing multiple parameters and 
their interactions, rather than just one parameter in isolation. 
 
2.2.4 Chemotaxis 
 
Chemotaxis is made up of cell migration and gradient sensing. The way in which neutrophils 
accomplish their main goal by moving through various environments is by making use of 
chemical gradients originating from the target area (Irimia, 2010). Neutrophil chemotaxis is 
the process by which these cells sense a chemoattractant gradient, then migrate towards the 
signal (Gambardella et al., 2013). Interestingly, as soon as neutrophils are in the range of an 
infection, they “choose to” ignore intermediary chemokines even though they make use of 7-
transmembrane-spanning G-protein-coupled receptors as well (Billadeau, 2008). They rather 
prefer to migrate towards N-Formylmethionine-leucyl-phenylalanine (fMLP) - a known 
bacterial chemoattractant - or complement component (C5a), which assists in the removal of 
pathogens (Billadeau, 2008). For neutrophils to migrate from circulation to the actual site of 
infection in tissue, they need to respond to various chemokines such as interleukin-8 (IL-8), 
TNF-α, complement peptides (e.g. C5a and C3a), and leukotriene B4 (LTB4). They also 
respond to chemicals released directly by bacteria itself such as fMLP (Mondal et al., 2012). 
All these different signals are needed as they play important roles in different pathways that 
assist in more effective neutrophil recruitment. 
In order to explain neutrophils chemotaxis preference, studies have shown that neutrophils 
prefer to migrate towards fMLP and C5a, even when their concentrations are significantly 
lower than that of chemokines and leukotrienes (Foxman et al, 1997), (Heit et al., 2002) ; 
(Billadeau, 2008). Billadeau (2008) noted that fMLP and C5a migration makes use of the 
mitogen-activated protein kinase (MAPK, p38) while most other chemokines are reliant on 
phosphatidylinositol-3-OH kinase (PI3K). This may explain why fMLP is often used as 
chemotaxin of choice in in vitro studies. The fact that fMLP – although specifically 
applicable to pathogen presence – also used the MAPK38 system, makes it a suitable 
alternative for C5a, which is more broadly applicable to all inflammatory scenarios, but 
which is more difficult to use given its endogenous presence (Billadeau, 2008). 
Returning to the mechanism(s) facilitating chemotaxis preference, Heit et al., (2008) has 
suggested that neutrophils are able to prioritize chemoattractant signals via phosphatase and 
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tensin homolog (PTEN). Interestingly, PTEN-deficient neutrophils that were migrating 
towards fMLP became disorientated when CXCL2 (another chemokine, also called 
macrophage inflammatory protein (MIP) was added, negatively affecting migrational 
accuracy. Also, when first migrating towards CXCL2, the cells did not change direction when 
fMLP was added, suggesting PTEN has a major role with regards to migratory decision 
making with regards to different chemoattractant (Papakonstanti et al., 2007). This 
mechanism has not been comprehensively investigated. The majority of research into PTEN 
[as well as Phosphatidylinositol (3, 4, 5)-triphosphate (PIP3) and PI3K] has been focused on 
their chemotaxis-related roles to facilitate macrophage mobility and directional accuracy via 
macrophage mechanical polarisation. The contribution of these phenomena are discussed in 
the next section. 
 
2.2.5 Neutrophil polarization 
 
Neutrophils are highly motile and have the ability to interpret and translate any 
chemoattractant gradient into the polarization of the cell and also the alignment of polarity 
and chemoattractant gradients to occur (Xu et al., 2010). Neutrophil polarization is the 
process that causes the neutrophil to undergo a mechanical shape change (elongation), 
showing a clear leading and tail end of the cell (Shi et al., 2009) (i.e. quite different from 
macrophage polarisation) in order for actual movement to take place. Polarization of 
neutrophils is very important in assisting cell movement: actin polymerization at the leading 
edge pushes the cell forward and actomyosin contractility at the rear end allows tail retraction 
to occur. At the leading edge there is continuous generation of F-actin meshwork that pushes 
the cell forward and at the tailing end constant dissolving of previous attachment occurs, this 
allows the cell to translocate and reattach creating movement (Weiner et al., 1999), 
(Srinivasan et al., 2003), (Shi et al., 2009).     
Polarization assists in faster translocation of the cell, but does not play a role in directionality 
of the cell during chemotaxis, although abnormalities in the process will affect the ability of 
the cell to maintain directional accuracy. Various cellular proteins are involved in the 
complexity of cellular propulsion.  
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2.2.5.1 PI3K, PIP3 and PTEN 
 
In order for chemotaxis to be effective, both motility and directional accuracy are needed, 
although the two do not seem to be directly interdependent. The exact contribution of all the 
key components involved in the leading and trailing edge of neutrophil migration is still not 
fully discovered, but better understanding is starting to emerge.   
Although Xu et al., (2003) reported that the chemoattractant signal is solely responsible for 
directionality during neutrophil migration, this is a somewhat outdated idea. Rather, the 
chemoattractant might be the initial step which dictates the direction in which the cell would 
like to go, but a variety of factors have to come into play to help the cell accomplish 
directionality and motility towards the chemoattractant. For a neutrophil to successfully 
migrate in the direction of the chemotactic signal, some synchronised events have to occur 
(Figure 2.2). A F-actin meshwork has to be formed in what becomes the leading edge of the 
cell, to facilitate forward propulsion (Petrie et al., 2009), (Kamakura et al., 2013), while 
actomyosin contraction has to occur at the trailing edge of the cell for detachment.  
Some of the regulators thought to function in the front (leading edge) are phosphatidylinositol 
3, 4, 5 –triphosphate (PIP3) and the small GTPases (e.g. Rac, PI3K and Cdc42), while in the 
rear other factors come into play (e.g. RhoA GTPase, phosphorylated myosin light chain 
(pMLC) and PTEN (Xu et al., 2010), (Kamakura et al., 2013). Especially the Rho family 
GTPases are crucial in initiating cell polarization and motility and are relied on strongly for 
chemotaxis (Srinivasan et al., 2003), (Pestonjamasp et al., 2006). 
 
Figure 2.2. Proposed model of neutrophil polarization from: (Gambardella et al., 2013) 
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As illustrated in Figure 2.2, at the leading edge, PI3K is responsible for synthesis of PIP3 
(Billadeau, 2008), (Heit et al., 2008). PIP3 accumulation at the leading edge is seen as an 
early and noticeable occurrence once cell polarization is initiated as a result of 
chemoattractant stimulation (Servant et al., 2000), (Hawkins et al., 2010) and has been linked 
to various cytoskeleton-based functions such as adhesion and migration (Hawkins et al., 
2006), (Mondal et al., 2012). In our context, PIP3 is required for the activation of the 
GTPases Rac (Gambardella et al., 2013) and Cdc42 by Dock2 (a PIP3-dependent guanine 
nucleotide exchange factor [GEF]) (Wang, 2009); (Berzat et al., 2010). Activated Rac and 
Cdc42 then signals for the accumulation of F-actin as well as focal inhibition of RhoA in the 
leading edge, thus effecting forward propulsion (Weiner et al., 2002), (Xu et al., 2003), 
(Berzat et al., 2010), (Gambardella et al., 2013).  This process is sustained by activated Rac, 
which seems to maintain PIP3 production by PI3K in a positive feedback loop. 
Simultaneously, at the rear end of the cell, a contrasting picture is seen: RhoA signalling 
seems to inhibit Rac activation and thus allows for the recruitment of PTEN to the rear. 
PTEN further inhibits PI3K (Vemula et al., 2010) and dephosphorylates PIP3 to 
phosphatidylinositol 4,5–bisphosphate (PIP2) (Gambardella et al., 2013), maintaining Rac in 
its inactivated form. This role of PTEN has been shown to be vital for the maintenance of 
directional accuracy (Billadeau, 2008), (Heit et al., 2008). Similarly, another phosphatase – 
SH2 domain-containing inositol 5-phosphatase (SHIP1) – has been illustrated to have a 
similar function to PTEN (Mondal et al., 2012). This group has also linked excessive PIP3 at 
the rear of a migrating cell to suboptimal anterior-posterior PIP3 gradient, which is needed 
for successful migration. This supports our earlier notion that directional inaccuracy is a 
result of suboptimal polarisation. Interestingly, the opposing actions on Rac in the front and 
back edge of the cell seem to occur independently of each other, although in a synchronised 
fashion. More research is required to more fully elucidate the connection between these 
occurrences. 
In my opinion, using PI3K as a marker for cellular migration would be a better choice for a 
marker than PIP3. As discussed above, it is the PIP3 gradient between the front and rear end 
of the cell that is most informative, rather than total concentration. Thus, accurate information 
can only be gained from image analysis type assessments. On the other hand, PI3K is 
generally accepted to only be found in the front of the cell, so that for this parameter, total 
expression would provide sufficient information.   
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The relative importance of the various role players have been investigated and argued to 
some extent. For example, disturbance of SHIP1 in neutrophils resulted in F-actin 
polymerization and PIP3 build-up across the entire cell (Nishio et al., 2007). This was 
associated with super-adherent neutrophils showing significantly inhibited migratory capacity 
(Nishio et al., 2007), suggesting importance of SHIP1 in neutrophil polarisation. However, it 
was noted that a loss of PTEN also allowed PIP3 and F-actin production to continue, which 
resulted in similarly inefficient chemotaxis (Mondal et al., 2012), arguing for importance of 
this phosphatase as well. Although much of the molecular mechanisms at play remains to be 
elucidated, there are some clues in the literature to suggest slightly different roles for PTEN 
and SHIP1. A study by Mondal et al., (2012) illustrated that the loss of SHIP1, but not of 
PTEN, led to an increase in cellular adhesion. Furthermore, a subsequent study by the same 
group demonstrated no loss of chemokinetic accuracy in SHIP1-deficient neutrophils toward 
fMLP (Mondal et al., 2012). Also, SHIP1-/- mice showed an increase in pro-inflammatory 
cytokine release and neutrophil recruitment (Strassheim et al., 2005), (Nishio et al., 2007), 
(Mondal et al., 2012). In contrast, neutrophils with experimentally altered PTEN genetics, 
showed relatively minor abnormalities with regard to cellular migration (Subramanian et al., 
2007), (Heit et al., 2008); (Schabbauer et al., 2010). However, these PTEN-compromised 
neutrophils exhibited decreased directionality of the response towards chemotactic signals 
(Heit et al., 2008). From this, it can be concluded that SHIP1 probably has the more 
important role in cell mobility via regulation of synchronised detachment and adhesion, while 
PTEN seems more important for maintenance of directional accuracy.  
Most surprisingly, neutrophils lacking any of PIP3-metabolizing enzyme’s PI3K, PTEN, 
SHIP1, or  neutrophils insufficient in  PIP3 levels as a result of  wortmannin treatment 
(Kamakura et al., 2013), all still showed maintenance of at least some degree of directionality 
during chemotaxis (Ferguson et al., 2007), (Nishio et al., 2007), (Hoeller et al., 2007). Thus, 
although the above literature does seem to suggest specific importance for the factors 
discussed, there remains significant redundancy. This phenomenon testifies once again to the 
importance of the innate immune system, but also opens the door for further research to more 
fully elucidate this complex puzzle. 
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2.2.5.2. ROCK 
 
RhoA/ROCK was mentioned in the above section, but we will be taking a closer look at how 
the family members of Rho-GTPase plays a vital role in managing certain cellular processes 
such as migration, proliferation and apoptosis (Shi et al., 2009), (Vemula et al., 2010). The 
main downstream effector of Rho-GTPase in the rear of the cell has been identified as p160-
Rho-associated coil-containing protein kinase (ROCK) (Vemula et al., 2010), (Heasman et 
al., 2011). Here, Rho-GTPs activates ROCK to assist the actomyosin-mediated contraction 
and tail retraction that is required for forward movement.  
Taking a closer look at ROCK specifically, there are two known isoforms of ROCK, namely 
ROCK1 and ROCK2, which shares more than 90% homology with their kinase domain 
(Nakagawa et al., 1996). The exact functional differences between ROCK1 and ROCK2 are 
not well understood, although the fact that varying levels of ROCK1 and ROCK2 activity 
throughout the body implies some functional specificity. For example, ROCK1 activity is 
lower than that of ROCK2 in lung endothelial cells, but higher in fibroblasts (Vemula et al., 
2010), although it remains controversial whether ROCK1 and ROCK2 exhibit functional 
redundancy (Zanin-Zhorov et al., 2016). For example, ROCK1 and ROCK 2 were shown to 
have similar roles with regard to cell cycle development and tumorigenesis (Kümper et al., 
2016) while having specific roles in the modulation of keratinocyte differentiation and 
cellular tail retraction/detachment (Yoneda et al., 2005). Thus, it seems as if the ROCK1 
versus ROCK2 function is dependent on the cellular system where it is expressed. 
From the innate immunity’s perspective , ROCK1 is thought to be needed for the stress fiber 
formation and the phosphorylation of the myosin light chain, while ROCK2 on the other hand 
has a stronger binding capacity to PIP2 than ROCK1 (Vemula et al., 2010). In a study on 8-
week old wild type and ROCK1 -/- mice, macrophages and neutrophils were extracted from 
bone marrow: ROCK1-deficient cells exhibited a 60% decrease in the overall ROCK activity, 
which was associated with both enhanced cell recruitment and enhanced migration in 
response to a variety of chemotactic stimuli, which coincided with increased PIP3 levels. 
ROCK1 deficiency resulted in increased PIP3 and AKT levels, which was ascribed to 
diminished PTEN activation, although no direct link was seen between PTEN and ROCK1 in 
the knockout animals. Vemula et al. (2010) concluded that ROCK1 is a regulator of PTEN, 
whose function is to limit excessive recruitment of macrophages and neutrophils during acute 
inflammation. Vazquez et al., (2001) showed similar results to Vemula et al. (2010) that the 
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loss of PTEN enhanced recruitment of neutrophils during experimental acute peritonitis. This 
is also in agreement with earlier studies (Papakonstanti et al., 2007) (Subramanian et al., 
2007) showing that PI3K activation resulted in ROCK-dependent PTEN inhibition and 
improved migration towards fMLP.   
Additionally, the amount of PIP3 as well as its localization within the cell have been reported 
to be positively associated with migration/chemotaxis and the recruitment of immune cells 
(such as macrophages and neutrophils) in response to multiple receptors being activated, as 
PTEN is a regulator of PIP3 (Vanhaesebroeck et al., 2001); (Hawkins et al., 2006). 
Furthermore, increased localization of PTEN in the rear of the cell, resulted in better 
neutrophil migration towards fMLP (Li et al., 2005). This role for PTEN and/or ROCK in 
phagocyte migration may identify these parameters as potential therapeutic targets with 
which to modify inflammation. However, it is important to note that the loss of PTEN has 
been linked to cancer (Billadeau, 2008). Thus, this avenue should be approached with 
caution. Nevertheless, from the results discussed above, ROCK1 seems to be an important 
negative regulator of cell recruitment and migration.  
In contrast, total ROCK-/- neutrophils have been described as having a tail-retraction defect  
(Pestonjamasp et al., 2006); (Worthylake et al., 2001), arguing for a positive effect of ROCK 
on at least cell migration. However, given the lack of ROCK-specificity of the knockout 
model used, it is difficult to interpret this result. Recently, ROCK1 and ROCK2 were 
suggested to have opposing effects in macrophage polarisation (Zandi et al., 2015). However, 
more research is required before conclusions can be made with regard to opposing effects for 
ROCK isoforms in neutrophils specifically. Given the lack of available literature on ROCK2, 
ROCK1 is currently probably the better isoform to assess for information on modulation of 
inflammation.  
 
2.2.5.3 Diaphanous-related Formin-1 (mDia1) 
 
Another known RhoA-GTP effector found in the front of the cell is diaphanous-related 
formin-1 (mDia1), a protein that has been known to regulate actin rearrangements 
(Gambardella et al., 2013). mDia1 is responsible for the elongation that occurs at the front of 
the cell by regulation of the unbranched actin filaments while ROCK is able to control pMLC 
levels and in return increase actin filament contractibility (Figure 2.3) (Gambardella et al., 
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2013). Shi et al., (2009) stated that neutrophils lacking mDia1 are unable to successfully 
polymerize actin, polarize and maintain directional migration and this is linked to the 
decreased activation of RhoA-ROCK pathways. mDia1 -/- neutrophils showed decrease in 
total distance covered, speed and directionality when migrating towards fMLP (Gambardella 
et al., 2013). ROCK induced regulations as well as the relocalization of phosphorylated MLC 
(pMLC) which is normally to the rear and sides of the cell was scattered randomly inside the 
cell resulting in problems with tail retraction and lateral pseudopodia (Shi et al., 2009). It can 
thus be concluded that the loss of mDia1 serves a role in coupling the chemoattractant-
triggered RhoA activation to the neutrophils cytoskeleton, but to also stimulate RhoA-ROCK 
pathway (Shi et al., 2009).  
 
 
Figure 2.3 Proposed model of RhoA signalling in the neutrophil by (Gambardella et al., 
2013). 
 
2.2.5.3 Summary  
 
From the studies discussed, it is clear that the process of chemotactic movement of 
neutrophils is an extremely complex one. In summary, it has been determined that for 
chemotaxis to be effective both motility and directional accuracy needs to be maintained and 
that they are not dependent on each other. Furthermore, polarization of a neutrophils gives a 
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clear leading and rear edge to the migrating cell, thereby enabling directional movement. 
Polarization is characterised by a number of synchronised events: F-actin formation at the 
leading edge that drives the cell forward, tail retraction of the rear which propels the cell 
forward, as well as maintained cell polarity via PIP3-gradient. It is believed that the F-actin 
meshwork is responsible for directionality, while the maintenance of the cell’s front-rear 
polarity is responsible for motility. The F-actin meshwork is controlled by activated Rac that 
is regulated by PI3K via Rac-GEF and this is what drives the cell forward. Activated Rac also 
stimulates PI3K, which in turn synthesis PIP3. In some cases it is thought that PIP3 is the 
driving force and in other cases Rac, but a consensus about the mechanism has been reached 
to some extent. Both the leading edge and the rear of the cell need to work in a synchronised 
manner to move the cell forward. The movement of the cell is thought to be achieved by 
positive feedback loops. The rear of the cell is able to detach from the substratum by 
RhoA/ROCK-dependent actomyosin contractile forces, which in turn allows a net forward 
translocation of the cell. During chemotaxis PI3K is localized to the front of the cell and 
PTEN to the rear of the cell, RhoA signalling inhibits Rac activation and allows the 
recruitment of PTEN to the rear. The fact that PTEN and PI3K are located in different parts 
of the cell means the play a pivotal role in the control of PIP3 being distributed to specific 
compartments. While chemotaxis is underway, an anterior-posterior PIP3 gradient needs to 
be obtained inside the cell and this can guide the cell into a certain direction, stimulating a 
type of compass. PIP3 plays a vital role in the stabilization of the front-rear polarity, the 
regulation of PIP3 via PI3K in the front of the cell pushes cell forward, while PIP3 can be 
down regulated by PTEN to PIP2 in the rear. PTEN is thought to be the main regulator in 
maintaining the front-back polarity. Excess PIP3 in the rear of the cell could disrupt the PIP3 
anterior-posterior gradient and it is needed for successful migration. SHIP1 marker was 
identified and reported to be found in the rear of the cell and is also able to phosphorylate 
PIP3 to PIP2. The loss of both PTEN and SHIP1 independently resulted in the same over 
production of PIP3 and the F-actin meshwork. However only SHIP1 deficient neutrophils 
showed an increase in cellular adhesion and not PTEN deficient cells. Therefore, PTEN is the 
main driving force in maintaining the PIP3 gradient between the leading and rear of the cell. 
While SHIP1 is to be a negative regulator of Ptdlns(3, 4, 5)P3 formation at the rear of the 
cell, assists in preventing the top-down Ptdlns(3, 4, 5)P3 polarity and lastly SHIP1 facilitates 
tail attachment and retraction. PTEN is directly associated with chemoattractant signalling via 
GPCR activation, while SHIP1 is involved in the regulation of integrin mediated adhesive 
responses. PI3K is thus a great marker for determining the expression of PIP3 at the leading 
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edge during migration. Increase in PI3K at the leading edge should result in an increase of 
PIP3 at the leading edge and the down regulation of PIP3 at the rear. Rho-GTPase plays a 
vital role in managing certain cellular processes such as migration, proliferation and 
apoptosis. RhoA GTP is found in both the front and rear of the cell, and that Rac and Cdc42 
are GTPases that promotes the production of F-actin in the leading edge, while Rho-GTPs 
such as ROCK are located at the rear and assist the actomyosin-mediated contraction and tail 
retraction that is required for forward movement. ROCK is thought to activate PTEN and in 
return PTEN phosphorylates PIP3 to PIP2. The loss of ROCK, increases PIP3 and Akt levels 
because of diminished PTEN activation, which in turn resulted in enhanced migration and 
enhanced F-action meshwork. This is where the results start to differ as some studies claim 
the loss of ROCK and PTEN will result in tail retraction problems and reduce neutrophil 
migration. 
 
2.3 Macrophages 
 
Apart from neutrophils, macrophages also has an important role to play in the inflammatory 
process. Unlike neutrophils, which are generally accepted to exist as one homogenous 
population, macrophages can be divided into different phenotypes with somewhat different 
functions. In this section, a brief overview on the relevant literature on macrophages is 
presented. 
2.3.1 Role of macrophages in inflammation 
 
Monocytes are highly active and versatile mononuclear phagocytes. After circulating in blood 
for a period of about 20 hours, monocytes differentiate into macrophages, which then leave 
circulation to enter tissue, where they can remain for the next 20 years, to provide local innate 
immunity (Geissmann et al., 2010), (Gordon, 2012), (Mia et al., 2014).  
Given the huge impact of inflammation in the sporting arena, the majority of research on 
inflammation and macrophages, in the absence of pathology, has been done with skeletal 
muscle injury as focus. In this context, macrophages are known to be of extreme importance 
for tissue repair, forming part of the late inflammatory phase of recovery (Smith et al., 2008).  
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The involvement of macrophages during the second phase of recovery have been established 
and are thought to include: clearing of cellular debris (including expended neutrophils) via 
phagocytosis; macrophage phenotypic shift from pro- to anti-inflammatory; inhibition of 
muscle cell apoptosis; secretion of factors that can assist in muscle precursor cell activation 
as well as growth; and release of cytokines and growth factors that can promote vascular and 
muscle repair (Massimino et al., 1997), (Li et al., 2001), (Gordon, 2003), (Chazaud et al., 
2003), (Järvinen et al., 2005), (Tidball, 2005), (Sonnet et al., 2006), (Summan et al., 2006); 
(Arnold et al., 2007), (Smith et al., 2008).  
However, in order for them to fulfil these very important roles to prepare damaged sites for 
tissue regeneration, it is vital for macrophages to migrate either from circulation, or from 
tissue where they have been residing, to damaged tissue. In the next section, I will review 
what is known about macrophage phenotyping, as it is a sub-theme in my thesis with regards 
to whether a phenotypic shift occurs.  
 
2.3.2 Macrophages phenotypes 
 
Macrophages can be classified into four main groups. Firstly, M1 (classically activated) 
macrophages – the release of which are regulated by TH1 cytokines – are known to secrete 
pro-inflammatory cytokines as well as ROS and display great microbicidal and tumoricidal 
properties (Tan et al., 2016). As is the case for neutrophils, ROS in pro-inflammatory 
macrophages plays an important role in the degradation of ingested material, but in excess, 
can induce apoptosis of the immune cell itself, which exacerbates (secondary) inflammation 
(Tan et al., 2016).  Alternatively activated macrophages are sub-divided into three sub-
populations: M2a macrophages are induced by TH2 cytokines (e.g. IL-4) and are known to 
secrete various specific markers (e.g. YM1, AMCase and Arginase 1) (Saclier et al., 2013) 
(Tan et al., 2016). These specific markers are linked to the synthesis of the extracellular 
matrix, angiogenesis and parasite clearance (Saclier et al., 2013), but are not thought to be 
present in significant quantities in the absence of chronic pathogenic infection or chronic 
inflammatory disease (e.g. chronic fibrosis).  M2b macrophages are activated by a mixture of 
toll-like receptor ligands and immune complexes to dampen inflammation (Saclier et al., 
2013). A literature search did not reveal many studies focusing on this particular phenotype, 
so that its relevance is uncertain at this point. Finally, and of specific relevance in the context 
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of inflammation, M2c macrophages produce high levels of anti-inflammatory proteins, such 
as IL-10 and transforming growth factor-beta (TGF-β) (Saclier et al., 2013), (Tan et al., 
2016). Both IL-10 and TGF-β are known to assist the cell in expressing cell surface markers 
like mannose receptor (MR/CD206) and scavenger receptor (SR/CD163) (Tan et al., 2016).  
M2 macrophages can be grouped by stimulating the cells with either IL-4, IL3, TGFβ or IL-
10 which in turn showed different distinctive activation profiles (Mantovani et al., 2004). 
This is done as there are many overlapping characteristics in the alternative M2 macrophage 
phenotypes apart from the IL-4 induced phenotype (M2a) (Tan et al., 2016). 
However, instead of existing as 4 distinct macrophage cell types, these cells seem to be just 
different phenotypes arising from one cell type only. The surrounding cellular environment 
seems to change macrophage phenotype by polarizing them, allowing them to perform their 
specific functions (Geissmann et al., 2010). The specific time-order of these different 
macrophage phenotypes has been defined, at least in the context of non-pathological tissue 
damage. Here, the first cells present at the site of injury are the pro-inflammatory M1 
macrophages, which seem to fulfil a function similar to that of neutrophils. After a few days 
they undergo a phenotype shift to become anti-inflammatory M2 macrophages (Arnold et al., 
2007), to facilitate resolution of inflammation. Interestingly, increased population of pro-
inflammatory macrophages has been reported in individuals suffering from autoimmune 
diseases ,(Kouwenhoven et al., 2001), (Menke et al., 2009), (Li et al., 2010), (Ciccia et al., 
2013), suggesting that a predominant macrophage phenotype may play an important role in 
modulation of inflammation, and thus perhaps cell types other than macrophages involved in 
the process.  
In support of this, manipulation of this phenotype shift has been proposed as therapeutic 
avenue and has been investigated to some extent. Kruger et al., (2012), showed that the use of 
an antioxidant treatment had beneficial effects on the resolution of inflammation and one of 
the ways it does this, is by facilitating a phenotype shift from M1 to M2 macrophages (this 
will be discussed later in more detail in section 4). Mia et al., (2014) similarly suggested that 
prolonged persistence of pro-inflammatory macrophages may lead to the prolongation of 
inflammation resolution. This group of researchers illustrated how human peripheral 
monocytes from both healthy and diseased (multiple sclerosis or spondylarthritis) donors may 
be polarised with either lipopolysaccharides (LPS) and IFN-γ, or IL-4, IL-1β and TGFβ, to 
yield M1 and M2 macrophage phenotypes respectively. This follows earlier work by the 
same group in models of autoimmune disease, where autologous infusion of pre-activated 
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anti-inflammatory M2 macrophages assisted in reducing pro-inflammatory M1 expression 
(Parsa et al., 2012), (Wållberg et al., 2005). Together, these studies point to manipulation on 
the macrophage phenotype as a viable target for therapeutic effect. 
Unfortunately, phenotyping of macrophages has been known to be quite the challenge. 
Currently, the convention for human macrophages is to classify M1 macrophages as those 
with high expression of CD86, CD274 and HLA-DR, while M2 macrophages exhibit high 
expression levels for CD206, CD163 and intracellular IL-10. It is important to note that this 
classification was derived from the experimental polarisation of in vitro cell populations. 
However, classification of cells isolated from whole blood is not a simple sorting process. 
Using the same six markers, Saclier et al., (2012) illustrated that many macrophage 
phenotypes were present in the same area at the same time, suggesting that the chronology of 
macrophage phenotype switch is not as uniform and synchronised unless subjected to a 
uniform, high-concentration stimulus, as employed in the polarisation protocols. Also, 
phenotype switching basically entails lowering of expression of some markers and increasing 
expression or others. Thus, since any primary macrophage population will consist of many 
cells in transition, much variation in terms of expression levels of all six markers is exhibited 
and no clear-cut phenotype categories can be distinguished, unless the stimulus for phenotype 
shift is of extreme magnitude/severity. This interpretation is in line with the opinion of the 
Mantovani group – an authority on macrophage phenotyping – who suggested that M1 and 
M2 macrophage phenotypes are extremes in a continuum of polarisation states (Sica et al., 
2012).  For this reason, the norm has become to investigate changes in phenotype shifts by 
stimulation of primary cell samples in vitro prior to typing (Mia et al., 2014). Much more 
work is needed on this topic, given both its complexity and its potential as target for 
intervention.  
Finally, in the context of this thesis, a phenotype switch in the periphery – e.g. as a result of 
supplementation – may affect the cytokine environment of the neutrophil, with predominance 
of pro-inflammatory M1 (and M2a in chronic inflammation specifically) cells creating a 
relatively pro-inflammatory environment, while M2c predominance may result in a more 
anti-inflammatory environment. Thus, the phenotype of macrophage may affect neutrophil 
activation and recruitment into tissue. It is thus important to consider changes in both cell 
types, and not just neutrophils. 
This concludes the review on the general functioning of the innate immune system in the 
context of inflammation. Given the focus of the thesis – investigation of the modulatory 
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effect of grape seed-derived polyphenols on inflammation – I will now switch to an overview 
of literature related to this natural medicine. 
 
2.4 Polyphenols  
 
Triterpenoids and polyphenols are plant-derived compounds that are known to have anti-
oxidative capacity and are able to some degree to provide alleviation against inflammatory 
stress (Dinkova-Kostova et al., 2005), (Morillas-Ruiz et al., 2006). The clinical significance 
of the anti-inflammatory capacity that polyphenols possess are still being debated. A few 
studies done on polyphenols have helped to shed some light on this issue.  
The common saying “too much of a good thing becomes a bad thing”, is applicable when it 
comes to oxidants and inflammatory processes. When the production of oxidants is far 
greater than the endogenous antioxidant capacity, oxidative stress arises (Petersen et al., 
2016). As discussed previously, inflammation plays a vital role in fighting off infection and 
tissue repair but also causes secondary damage. As recently reviewed (Petersen et al., 2016), 
the inflammatory immune response and oxidative stress are interlinked processes. Therefore 
therapeutic treatments that can alleviate the cumulative effects of both are being investigated. 
Here, an overview of a variety of plant extracts or plant-derived compounds and polyphenols 
that have been proposed to have anti-inflammatory and/or antioxidant effect is provided. 
In the context of cardiovascular disease, much research has focused on modulatory effects of 
polyphenols. For example, quercetin and resveratrol, both polyphenols contained in red wine, 
were shown to interfere with pro-inflammatory nuclear factor kappa-light-chain enhancer of 
activated B cells (NF-κB) signalling of thrombin by preventing adenosine nucleotide 
secretion from activated platelets (Kaneider et al., 2004). This is a significant finding, as 
thrombin is thought to play a role in facilitating inflammation and reparative responses to 
vascular injury (Ruf et al., 2003), while thrombin-related down-regulation of endothelial 
ectonucleotidase activity results in high adenosine diphosphate (ADP) and adenosine 
triphosphate (ATP) levels, which in return leads to the activation of platelets, leukocytes and 
endothelia (Daniel et al., 1999), (Kaneider et al., 2004). Thrombin-activated platelets are 
known to cause an increase in neutrophil respiratory bursts, but resveratrol and quercetin was 
found to inhibit these bursts, as well as neutrophil migration towards conditioned media from 
platelet cultures exposed to thrombin (Kaneider et al., 2004). Interestingly, these 
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polyphenols, such as epigallocatechin 3-gallate (EGCG), which is the major polyphenol 
present in green tea was seen prevent endothelial dysfunction and  inhibit NF-κB activation 
(Ahmad, Gupta and Mukhtar, 2000). This was seen when A431 cancer cells were exposed to 
an inflammatory stimuli, such as LPS by disturbing the Rho-GTPase-dependent signalling 
pathways (Chen et al., 1996), (Ahmad et al., 2000), (Balasubramanian et al., 2002).  
Similarly, vegetables high in dietary fibre have been linked to a decrease in the prevalence of 
coronary heart disease (CHD), stroke and cardiovascular mortality (Gaziano et al., 1995), (Li 
et al., 2001),  (He et al., 2006). A large group of vegetables of the Brassicaceae family – 
including broccoli, cauliflower, sprouts and kale are known for their anti-oxidative and anti-
inflammatory capacity and therefore have been studied within the last decade with great 
interest (Kuntz et al., 2014). Brassicaecae has a significantly high content glucosinolates, 
polyphenols and phenolic acids (Cartea et al., 2010), (Velasco et al., 2011). Studies in 
humans have shown that an atherogenic diet’s negative effects can be prevented by 
consumption of Brassica oleracea L.  (Noh et al., 2009), (Sankhari et al., 2012). 
Furthermore, in vitro studies elucidated certain particulates in Brassicaceae were able to 
lower the level of cellular adhesion molecule expression, which are known role players in 
inflammation and atherogenesis (Chao et al., 2013).  
Of particular interest and relevant to the specific topic of this thesis is the adhesion of 
cultured neutrophils to TNF-α-stimulated endothelial cells that decreased from 57% to 36%  
after pre-incubation of methanolic and water extracts of curly kale leaves, while adhesion to 
non-stimulated endothelial cells was not affected (Kuntz et al., 2014). In addition, in the same 
study, TNF-α-induced increased expression of VCAM, ICAM and E-selectin mRNA was 
attenuated after treatment. Similar results was also reported for kaempferol-3-O-sophoroside, 
another flavonoid found in high amounts in cabbage (Kim et al., 2011). These effects were 
ascribed to potential modulation of the redox NF-κB signalling pathway – similar to the 
mechanism suggested for quercetin and resveratrol in the context of thrombin. 
Also in the context of cancer, Brassicaceae flavonoids – specifically the polyphenols – were 
shown to have similar beneficial effects via inhibition of TNF-α induced ICAM-1 and 
VACM-1 expression in different cancer cell lines (Chen et al., 2004); (Jung et al., 2012); 
(Jang et al., 2012). The authors suggested that the beneficial effects were due to their anti-
oxidant capacity. Additionally, a study by (Engelbrecht et al., 2007) using grape seed 
proanthocyanidin extract (GSPE) on colon cancer cells (CaCo2 cells) to assess its chemo-
preventative/anti-proliferative capacity showed that an increase in apoptosis was associated 
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with inhibited PI3K expression and decreased PKB 𝑆𝐸𝑅473 phosphorylation (Engelbrecht et 
al., 2007). 
Curcumin is another well-known polyphenol, which is found in turmeric curry spice. It gives 
the yellow colour we are familiar with and is also known to possess anti-inflammatory, anti-
oxidative, anti-proliferation and anti-angiogenic activities. For example, curcumin down-
regulated the adherence of neutrophils to HMGB1-activated endothelial cells and their 
migration towards chemotactic fMLP in concentration dependent manner. Furthermore, 
curcumin attenuated HMGB1-mediated increased in VCAM-1, ICAM-1 and E-selectin 
expression (Kim et al., 2011). High mobility group box 1 (HMGB1) protein up-regulates pro-
inflammatory cytokines in several inflammatory diseases (Kim et al, 2011) and increased 
extracellular HMGB1 accumulation is indicative of cell or tissue damage  (DeMarco et al., 
2005), (Erlandsson-Harris et al., 2006). 
From these studies, it is clear that the systems modulated by polyphenols are inflammation 
and oxidative stress, i.e. not disease-specific mechanisms. Several studies have illustrated the 
interlinked nature of inflammation and antioxidants in the context of plant medicine. For 
example, Guabiju extracts have antioxidant properties and are able to prevent neutrophil 
chemotaxis towards lipopolysaccharides. Similarly, quercetin, another plant derived 
antioxidant is known to also have anti-inflammatory properties (Andrade et al., 2011) 
(Derlindati et al., 2012). Thus, the modulation by these systems by polyphenols, particularly 
as preventative therapy, is gaining popularity with end users and researchers alike. One of the 
most comprehensively studied natural polyphenols, apart from resveratrol and quercetin, is 
the proanthocyanidins, which are also derived from grapes and which is the intervention 
chosen for this thesis. This is the focus in the next section.  
 
2.4.1 Grape-derived polyphenols  
 
As mentioned, the inflammatory process consists of the removal of debris and the activation 
of the cytokine facilitated process that assists in the regeneration (Farges et al., 2002); 
(Hodgetts et al., 2006). However, it is also known that phagocytes, and in particular 
neutrophils, causes damage to otherwise healthy tissue in the process. Inhibition of neutrophil 
oxidative burst has for example been shown to reduce inflammatory secondary damage by 
more than 80% in a model of ischaemia-reperfusion injury in mice (Tidball, 2005). Given the 
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requirement for inflammation for pathogen destruction, as well as in preparation for tissue 
repair, global inhibition of the process is not an option. Therefore, a more targeted approach 
is required. Several research groups have investigated clinical effects of grape-derived 
products, but only a few focused on specific potential therapeutic cellular targets. 
Proanthocyanidolic oligomers (PCO) is a group of polyphenols commonly derived from 
grapes. PCO has proven to be beneficial in the inflammatory process, using both in vivo and 
in vitro models, as well as chronic and acute supplementation protocols. Our research group 
has been investigating physiological benefits of grape seed-derived proanthocyanidolic 
oligomers (PCO) for a number of years, particularly in the context of inflammation and 
muscle damage. The data available has shown that in vivo PCO treatment hastens skeletal 
muscle recovery from injury in rats via modulation of the inflammatory response (Myburgh 
et al., 2012), (Kruger et al., 2012), (Kruger et al., 2014). Two main mechanisms of PCO have 
been illustrated in rats; firstly, PCO supplemented rats showed a significant decrease in the 
amount of neutrophil infiltration to the site of experimental, standardised and controlled 
skeletal muscle injury – a phenomenon well-known to decrease secondary damage (Tidball, 
2005). Secondly, supplemented rats showed earlier macrophage migration towards the 
injured tissue as well as faster resolution of inflammation (Kruger et al., 2012).  
Subsequently, these previous studies have shown that in vivo PCO supplementation allows 
classically activated (M1) macrophages to switch to an anti- inflammatory phenotype, named 
alternatively activated (M2c) at an earlier time point after injury and even while still in 
circulation (Kruger et al., 2014). Such a change is much desired in the context of 
inflammation, since M2 macrophages cannot cross endothelial membranes (Kalkman et al., 
2016) and will thus not enter tissue, which could explain the faster resolution of 
inflammation.  
In terms of human studies, there is no or very little literature available. Preliminary data from 
a study by our research group, in humans subjected to plyometric exercise, suggest that the 
same benefits may be achieved in human models of mild injury. However, this data is not 
conclusive due to the relatively small-scale injury characteristic of this model, which may 
mask some effects.  However, recent in vitro studies using human cells ex vivo or human cell 
line models have shown positive results.  For example, in an ongoing study, there is data 
proving neutrophil chemokinesis is positively affected by in vitro supplementation of human 
leukocytes with PCO (Petersen et al., 2016). The treated cells exhibit more directed 
movement, suggesting the likelihood of early-phase inflammation facilitated by neutrophils 
Stellenbosch University  https://scholar.sun.ac.za
 25 
to be more effective and thus shorter in duration. Based on these findings, we therefore 
believe that the PCO product – which is commercially available - is not only safe for human 
consumption, but also beneficial to general health. 
Given these promising effects of PCO treatment, the investigation of potential mechanisms 
by which these anti-inflammatory effects are achieved was undertaken. The anti-
inflammatory potential of grape seed-derived PCO in this context was assessed. 
Both chronic preventative and acute post-injury PCO treatment in rats subjected to 
experimental skeletal muscle contusion injury was shown to effectively limit neutrophil 
migration into the damaged site. This is associated with faster muscle stem cell recruitment 
and faster tissue repair (Myburgh et al., 2012), (Kruger et al., 2012). Also, in this model, 
PCO facilitated an earlier macrophage phenotype switch from pro- to anti-inflammatory 
phenotypes (Kruger et al., 2014), as well as an earlier anti-inflammatory shift in the cytokine 
profile both in muscle and circulation (Myburgh et al., 2012). Specifically, injury-induced 
increased levels of TNF-α – a pro-M1 signal – decreased sooner in the PCO-treated animals, 
while IL-10 – a pro-M2 signal – increased earlier. This is in agreement with a study including 
resveratrol, which reported an inhibition of pro-inflammatory cytokine (IL-6 and IL-8), as 
well as down-regulation of activated neutrophils (Donnelly et al., 2004), (Kruger et al., 
2014);. In terms of the molecular targets of PCO, from these results it is not clear whether 
macrophages were directly influenced or rather indirectly due to the downstream result of the 
limited neutrophil infiltration and associated damage. However, the results clearly indicate 
that either the mobilization or the extravasation capacity of neutrophils are impacted by PCO. 
The interpretation of these results is supported by another study which has shown that 
proanthocyanidin supplementation inhibits TNF-α and cytokine-induced neutrophil 
chemoattractant (CINC-1) levels in the pleural exudates in a rat model of carrageean-induced 
inflammation (Garbacki et al., 2004). Suggesting once again the involvement of 
proanthocyanidin in hindering neutrophil migration.  
In addition to the potent anti-inflammatory effect of PCO supplementation, our research 
group has been at the forefront of elucidating the increase in antioxidant status in skeletal 
muscle tissue after PCO treatment (Myburgh et al., 2012). MPO levels were inversely 
correlated with the decrease in the amount of neutrophils present at day 1 post injury 
(Myburgh et al., 2012). This clearly illustrated the interlinked nature of these responses, as 
well as interventions aimed at modulation of either of the two. Additionally, another study 
demonstrating a dose dependent ability of GSPE to scavenge free radicals in vivo and in vitro 
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reported that GSPE was significantly better than vitamins C, E and β-carotene at scavenging 
free radicals and preventing free radical-induced lipid peroxidation, as well as DNA damage 
(Bagchi et al., 2000).  
A factor that has not been previously investigated in regards to PCO has been employed in 
this study: its effect on adhesion molecules. However, the investigation of adhesion 
molecules have been included in the above mentioned groups’ previous research. For 
example, one study on human umbilical vein endothelial cells (HUVECs) reported that TNF-
α-stimulated VCAM-1 expression was dampened by grape-derived proanthocyanidin 
treatment (Sen et al., 2001). Similar results were reported for Activin, a new generation 
antioxidant which is also a grape seed derived proanthocyanidin (Kalfin et al., 2002).  
The study performed by (Kalfin et al., 2002) assessed the effectiveness of Activin to decrease 
the modulation of adhesion molecules in plasma (as an effect of an inflammatory response) 
from patients suffering from systemic sclerosis (SSc) was investigated. Briefly, patients were 
orally supplemented with 100mg/day of Activin for one month – this was associated with a 
significant reduction in the disease-related increased adhesion molecule (VCAM, ICAM, E-
selectin) expression in plasma (Kalfin et al., 2002). Also, malondialdehyde (a well know 
oxidative stress marker) was significantly reduced in SSc patients after Activin treatment 
(Kalfin et al., 2002).  
From these previous studies, it is clear that grape seed derived PCO has both anti-
inflammatory and anti-oxidative benefits. Although only a few parameters have been 
identified which consistently indicate positive effects, the exact mechanism(s) involved has 
not been comprehensively elucidated. Additionally, few studies involving the 
supplementation of humans with PCO have been done and there are no previous studies 
investigating the exact mechanism of neutrophil chemotaxis. Since the modulation of 
inflammation is not only relevant to individuals in the sporting arena or aged individuals, but 
also to the aetiology and thus treatment of various chronic disease states, a more complete 
understanding of the mechanisms affected by PCO is of high relevance to society as a whole. 
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2.5 HYPOTHESIS AND AIMS 
 
 Hypothesis 
 
Before clinical trials may be undertaken in a pathological or at least compromised population, 
experimental treatments are subjected to testing in healthy individuals. Given the relatively 
non-extreme anti-oxidant and anti-inflammatory effects reported for PCO in the literature, we 
hypothesised the following: 
- That PCO will be safe for consumption in terms of blood coagulation 
- That few or no statistically significant clinical effects of PCO will be evident in a population 
without a basal inflammatory condition, but that PCO will affect molecular targets which 
may alter neutrophil chemokinesis 
 
 Aims  
 
- To assess effect of 2-week PCO consumption on blood coagulation function 
- To elucidate molecular targets of PCO in neutrophils, which may explain PCO-associated 
differences in neutrophil chemokinesis 
- To confirm PCO-associated macrophage phenotype shift in human model 
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3.  CHAPTER 3: METHODS AND MATERIALS 
 
3.1 Study design and ethical consideration 
To elucidate cellular mechanisms that may contribute to the polyphenol-induced effects on 
neutrophil chemokinesis previously reported, a longitudinal, placebo-controlled, double-
blind, human in vivo study design was chosen. Ethical clearance for all protocols was 
obtained from the Stellenbosch University Subcommittee C Human Research Ethics 
Committee (8th January 2016, M15/09/040) prior to subject recruitment. The study was 
conducted according to the SA MRC ethical guidelines, guidelines for good clinical practice 
and the International Declaration of Helsinki. (See Addendum I) 
 
3.2 Subject recruitment 
Both males and females between the ages of 18-25 years of age were recruited. Recruitment 
took place by advertisements on campus notice boards. A total number of 18 healthy 
individuals were selected based on inclusion and exclusion criteria. Inclusion criteria 
included any person aged 18 to 25 that apparently healthy, not on any type of supplement, 
recreationally active and non-smoking. Exclusion criteria excluded individuals with known 
inflammatory disease, chronic disease, or currently suffering from a condition with known 
inflammatory component, such as sinus or hayfever, from the study.  Subjects were instructed 
to refrain from taking vitamin,  anti-oxidant and anti-inflammatory products and not 
permitted to perform any strenuous exercise for a period of 14 days prior to initiation of the 
protocol, as well as for the duration of the entire protocol. All subjects were required to 
refrain from all types of exercise for a period of 24 hours prior to each sample collection time 
point. (See Addendum H) 
 
3.3 Protocol outline 
All volunteers were instructed to read, ask questions and sign their consent forms before 
enrolment into the study. After the 2-week pre-study wash out phase, participants were given 
detailed instructions, including a schedule for their three required laboratory visits. Subjects 
were required to report to the Exercise laboratory ( Department of Physiological Sciences, 
Stellenbosch University) on days 0 and 14 for baseline and post-intervention follow-up, as 
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well as to Pathcare Laboratories (4 Saffraan Avenue, Stellenbosch) on day 7. (In order to 
increase compliance to the protocol, participants were reminded of their various appointment 
dates and times for the duration of the study. Participants were also reminded of the various 
do’s and do not’s prior to the study. 
On each of these occasions, blood samples were obtained by venepuncture from a forearm 
vein, by an experienced and qualified phlebotomist. On days 0 and 14, 8ml heparin blood and 
8ml ethylenediaminetetraacetic acid (EDTA) blood was obtained from each patient, for 
assessment. The samples were collected at room temperature and centrifuged immediately 
after all samples were collected. 8ml heparin blood was used for the neutrophil migration 
assay, immunohistochemistry staining as well as flow cytometry analysis on neutrophil 
adhesion markers. While 8ml EDTA blood was used for flow cytometry analysis on 
macrophage phenotype markers. On day 7, a 2ml sodium citrate anti-coagulated blood 
sample was obtained, for the assessment of coagulation status, which was included as safety 
measure only. (See Addendum A) 
 
3.4 Intervention 
The grape seed-derived polyphenol used was analysed an independent laboratory (LC-MS 
laboratory, Central Analytical Facility, Stellenbosch University) to be a proanthocyanidolic 
oligomer made up of catechin, epicatechin and proanthocyananidin B). Accoring to the 
supplier’s Certificate of Anaylsis, the PCO content of Oxipoven ™ is 70mg per capsule. The 
daily recommended dosage is 1-2 capsules with water after a meals. Participants were 
instructed to take two capsules, once a day for 14 days, starting on day 0 (i.e. after baseline 
blood draw). And after a two week wash out period. 
 
3.5. Sample analysis 
 
3.5.1. Monocyte isolation for flow cytometry 
 
Blood from two EDTA vacationers were used for monocyte isolation. Buffy coats contain all 
circulating leukocytes, together with residual erythrocytes and platelets, this was layered onto 
Histopaque 1.077g/ml (sigma-Aldrich, #10771) at 2:1 ratio and centrifuged at 400 x g for 
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30min at 23°C, without brake. The Erythrocytes and Peripheral Blood Mononuclear Cells 
(PBMCs) were collected with a plastic Pasteur pipette and washed twice in PBS-EDTA (1x 
Phosphate Buffered Saline containing 0,5 M Ethylenediaminetetraacetic acid) (Sigma-
Aldrich, #P4417 + #E9884) and centrifuged at 300 x g for 10 min at 23°C. Purified PBMCs 
were resuspended in RPMI 1640 without phenol red (Sigma-Aldrich, #R0883), containing 
10% FBS (Fetal Bovine Serum) (Sigma-Aldrich, #12003C) and layered onto a 42.56% iso-
osmotic 1.131 g/ml percoll (Sigma-Aldrich, #E0414) solution at a 1.25:1 ratio. The iso-
osmotic percoll solution consisted of 48.6% advanced RPMI 1640 with phenol red (Life 
Technologies, #12633-020), 42.56% percoll, 5.4% FBS and 3.44% 10x PBS. Centrifugation 
at 550 x g for 30 min at 23°C, without brake and allowed for the separation of monocytes 
from PBMCs to occur. The white ring containing monocytes was collected with a plastic 
Pasteur pipette and washed once in PBS-EDTA at 400 x g for 10 min at 23°C, without brake. 
Pellet was resuspended in 1ml Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD 
bioscience #554714) and kept in the fridge at 4°C for 20min to allow for the fixation of cells. 
After fixation, cells were centrifuged at 400 x g for 5 min at 4 °C. Cells were resuspended in 
1ml cytoperm/wash, (BD bioscience #554714) and centrifuged under the same conditions. 
Cells were resuspended in PBS and aliquotted into different reaction vials (one for 
“unstained” counting and one “stained”). The 7 antibodies required for monocyte 
phenotyping BD – Anti-CD86 APC (#555660), BD – Anti-CD163 Per Cp-Cy5.5 (#563887), 
BD - IL-10 BV 421-Viral HU (#564053), BD - Anti-HLA-DR SPC-Cy7, CE (#335831), BD 
– Anti-CD206 BB515 (#564668), BD-Anti Myeloperoxidase, MPO, PE (#341642) BD-Anti-
CD274 PE-Cy7 (#558017) were added to the “stained” reaction vial. Thereafter, all vials 
were closed with tin foil and placed in the incubator for 10 min, 95% 𝐶𝑂2𝑎𝑛𝑑 5% 𝑁2 to 
allow for cell labelling. This was followed by centrifugation at 1600 rpm for 5 min at room 
temperature, resuspended in 1x PBS and overnight storage in the dark, at 4°C. Flow 
cytometry analysis was performed the next day. (See Addendum B) 
 
3.5.2 Neutrophil Isolation for Flow Cytometry and Migration 
 
Blood from two Heparin vacationers were used for Neutrophil isolation. 4ml heparin anti-
coagulated whole blood was layered onto Histopaque 1.077g/ml (Sigma-Aldrich, #10771) at 
2:1 ratio and centrifuged at 1800rpm for 30min at 23°C, without brake. Four different layers 
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of blood were formed, the sediment containing neutrophils and erythrocytes was taken by 
removing the supernatant. Sediment was mixed with equal volume of 6% Filtered Dextran 
(6g Dextran and 50ml 1x PBS) (1x Phosphate Buffered Saline, Sigma-Aldrich, #P44170) at 
room temperature and incubated at 37°C, 95% 𝐶𝑂2𝑎𝑛𝑑 5% 𝑁2 for 45min, to allow 
sedimentation of erythrocytes. Neutrophil rich supernatant resuspended in 1x PBS and 
centrifuged at 290xg for 10min at 4°C, this step was repeated. Cells were resuspended in 
RPMI and an automated cell count was performed on (CellDyne 3700Cs, Abbott 
Diagnostics; Germany). The final neutrophil pellet was resuspended in the desired volume of 
RPMI to achieve the cell concentration of +/- 1x106cellls/ml. (Protocol Continues 3.5.5) 
For Flow Cytometry preparation - half of the neutrophils isolated were used or this 
procedure. With a cell concentration of 1x106cells/ml, samples were centrifuged at 1500rpm 
for 10min at 4°C.  Pellet resuspended in PBS (1x Phosphate Buffered Saline, Sigma-Aldrich, 
#P44170). The neutrophils were aliquotted into different reaction vials (one for “unstained” 
counting and one “stained”). Surface marker antibody BD – Anti-CD66B FITC (#555724) 
was added to the “stained” reaction vial and placed in the fridge for 30min at 4°C, covered 
tinfoil. 1x PBS(1x Phosphate Buffered Saline, Sigma-Aldrich, #P44170)  was added and 
centrifuged at 1800rpm for 6min at 23°C.  
Cells were resuspended in Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD 
bioscience #554714) and placed in the fridge for 25min at 4°C covered in tinfoil. After cell 
Fixation, cells were washed with cytoperm wash (BD bioscience #554714) and centrifuged at 
1800rpm for 6min. Cells were then resuspended in PBS and BD–Anti-CD106, (VCAM-
1)PerCP-Cy5.5(#563525) and BD–Anti-CD54, (ICAM-1) BV421 (#566262) was added to 
the “stained” reaction vial and placed in the fridge for 30min at 4°C, covered tinfoil. Cells 
were washed with cytoperm wash (BD bioscience #554714) and centrifuged at 1800rpm for 
6min. Cell were resuspended in 500ul 4% paraformaldehyde and placed in the fridge 
overnight at 4°C. Flow cytometry analysis was performed the next day. (See Addendum C 
and D) 
 
3.5.3 Macrophage phenotype flow cytometry analysis 
 
Macrophages were isolated and single and multiple stain solutions were prepared a day prior 
for flow cytometry analysis (D FACSAria cell sorter, Becton Dickinson, USA), using D 
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FACSDiVa v6.1.3 software to determine the Median Fluorescent Intensity (MFI) of each 
marker. Populations were filtered, relocated and to flow cytometry tubes and immediately 
analysed. Unstained samples were prepared to determine background fluorescence. Single 
stain samples (containing only one marker) were used for fluorescent signal optimisation and 
compensation for potential spill-over between fluorophores. Multiple stain samples were used 
for data collection and labelled with the following markers: M1 [Anti-CD86 APC (#555660), 
BD-Anti Myeloperoxidase, MPO, PE (#341642), BD-Anti-CD274 PE-Cy7 (#558017), BD - 
Anti-HLA-DR SPC-Cy7, CE (#335831)]and M2[BD – Anti-CD163 Per Cp-Cy5.5 
(#563887), BD – Anti-CD206 BB515 (#564668), BD-Anti-CD274 PE-Cy7 (#558017)]. The 
appropriate lasers were sued to excite fluorophores and emission was captured using 
appropriate band filters. Data collection was done by recording 3𝑥105 events for every donor 
in triplicate and thresholds were set up by recording 8𝑥106 events. Technical flow cytometry 
procedures were done by a trained staff member of the Central Analytical Facility (CAF) at 
Stellenbosch University, however I did undergo basic training and was able to perform my 
own analyses, but due to time constraints of my study this was not always possible. A 
macrophage M1 and M2 markers at basal levels were established on day 0 and day 14 for 
both placebo and active to determine the macrophage phenotype profile of each participant. 
This would indicate whether PCO treatment provided a phenotypic shift.  
 
3.5.4 Neutrophil adhesion flow cytometry analysis 
 
Neutrophils were isolated and single and multiple stain solutions were prepared a day prior 
for flow cytometry analysis (D FACSAria cell sorter, Becton Dickinson, USA), using D 
FACSDiVa v6.1.3 software to determine the Median Fluorescent Intensity (MFI) of each 
marker. Populations were filtered, relocated and to flow cytometry tubes and immediately 
analysed. Unstained samples were prepared to determine background fluorescence. Single 
stain samples (containing only one marker) were used for fluorescent signal optimisation and 
compensation for potential spill-over between fluorophores. Multiple stain samples were used 
for data collection and labelled with the following markers: BD – Anti-CD66b FITC 
(#555724) BD–Anti-CD106, (VCAM)PerCP-Cy5.5(#563525) and BD–Anti-CD54, (ICAM) 
BV421 (#566262)   
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The appropriate lasers were sued to excite fluorophores and emission was captured using 
appropriate band filters. Data collection was done by recording 3𝑥105 events for every donor 
in triplicate and thresholds were set up by recording 8𝑥106 events. Technical flow cytometry 
procedures were done by a trained staff member of the Central Analytical Facility (CAF) at 
Stellenbosch University, however I did undergo basic training and was able to perform my 
own analyses, but due to time constraints of my study this was not always possible. A 
neutrophil cellular adhesion marker’s expression at basal levels were established on day 0 
and day 14 for both placebo and active participants (See Addendum C) 
 
3.5.5 Chemotactic neutrophil migration assay 
 
For migration- half the neutrophils that were isolated were used for migration. Normally, in 
vitro neutrophil migration assays are performed in a Dunn chamber (Sapey et al., 2011), 
(Sapey et al., 2014) or by making use of microfluidics systems (Irimia et al., 2006), (Irimia, 
2010), while videomicroscopy in commonly used for in vivo investigations (Germain et al., 
2008). However, none of these models allowed for immunostaining of cells at the endpoint, 
as they are all closed systems. Thus, mechanisms cannot be directly linked to functional 
outcome. Thus, for the purposes of this thesis, a novel migration assay was developed, by 
making used of an 8-chamber slide 75ul of 1x106cellls/ml (neutrophils) were seeded to the 
bottom left hand corner of an 8-well plate. 75ul fMLP [100ug fMLP (Sigma-Aldrich, 
#F3506) solution with HBSS (Hanks Buffer Solution, ThermoFisher Scientific, #24020091)] 
or instead 75ul RPMI 1640 with phenol red (Life Technologies, #12633-020) was plated in 
the top right hand corner, (each well had a duplicate and a control that was replaced with 
RPMI instead of fMLP. The neutrophil migratory paths were visualized by combining time 
lapse, images were acquired every 3 seconds per well for 40minutes and taken at 20x 
magnification using an Olympus Cell system IX-81 inverted fluorescent microscope system 
with an F-view cooled CDC camera (Soft Imagining Systems) at 37°C. Image J (Java 
Software) was used to track the movement of Neutrophils and, measure distance covered as 
well as distance from start using the Mtrack J plugin. Neitrophil tracks were quantified by 
measuring the total distance they moved (from point to point) and linear distance they 
covered (straight path from start to finish).  
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3.5.6 Immunohistochemistry 
 
After live cell tracking, 75ul 4% (v/v) paraformaldehyde in PBS and 75ul RPMI-1640 with 
phenol red (Life Technologies, #12633-020)  was added into each well, to fixate cells and 
then incubated at 37°C 95% 𝐶𝑂2𝑎𝑛𝑑 5% 𝑁2  for 10min. After 10min excess media was 
removed and wells were washed with 1x PBS (1x Phosphate Buffered Saline, Sigma-Aldrich, 
#P44170). Cells were then permeabilized with 0.1% Triton X-100 for 5min. Wells were 
washed with 1x PBS again, 1% BSA (Bovine Serum Albumin Fraction V, Roche 
#10735078011) (1x PBS) was used as a blocking solution for 20min. Primary conjugated 
antibodies (Anti-ROCK1, Alexa Fluor 488 #AB205432 and Anti-PI3K #AB202668 Biocom 
Biotech) were added and left covered in tinfoil overnight in the fridge at 4°C. The next day, 
wells were washed with 1x PBS. 1% Dappi (20ul Dappi in 2ml 1x PBS), a blue nuclei 
staining marker was added for 10min. Wells were then washed with 1x PBS. Cells were 
ready for visualization on the Carl Zeiss LSM780 confocal microscope with ELYRA S.1 
Superresolustion platform (Carl Zeiss, Germany) using ZEN Lite 2012 imagiging software 
(blue and black version). Images (between 1-2) were taken per well in the desired area of 
chemotaxis (point for contact with chemotaxin or RPMI) and this allowed for qualitative and 
quantitative analysis. Taking images of one 8-well plate can take up to one hour. This was 
done by a trained staff member of the Central Analytical Facility (CAF) at Stellenbosch 
University (See Addendum E) 
 
3.5.7 Immunohistochemistry analysis 
 
Using ZEN Lite (version 2012 blue and black) the images taken could be analysed. Images 
were uploaded, and analysed one at a time. One image has between (20-120) neutrophils that 
are stained and need to be individually circled, thereafter by individually clicking in each 
circled cell and intensity reading for both ROCK (stained green) and PI3K (stained Red) is 
given and needs to be recorded manually. After completing this task which can be quite 
tedious as it can take up to 4 hours per 8 well dish. However when calculating co-localization 
coefficients of each marker, the ZEN lite program can generate a table for all the cells in the 
entire image, this can then be saved. Co-localization is defined as the presence of two or more 
different pixels occupying the same space, and in this case in the neutrophil. The value range 
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is between (0-1), 0 – no colocalization and 1 being all pixels are co-localized. The value is 
determined by the relative number of pixels in a channel (PI3K or ROCK) compared to the 
total number of pixels above the threshold.  
 
3.5.8 Statistical Analysis 
 
All statistical analysis was performed by Dr Martin Kidd, a trained and experienced 
biostatistician, at Stellenbosch University using Statistica (version 13.2).  Data was analysed 
for normalcy of distribution, where after main effects of treatment was assessed by 
parametric and non-parametric ANOVA and Post Hoc Fischer’s LSD tests. All data obtained 
from this analysis was then further analysed in Excel 2010. All Graphs data is presented at 
means and ± SEM (standard error of means), while tables are presented as means and ± SD 
(standard deviations).  A p-value of <0.05 was considered statistically significant. 
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4.  CHAPTER 4: RESULTS 
 
4.1 Effects of Placebo and PCO Treatment on Haematological 
Parameters 
Given the reports on altered adhesion molecule expression after PCO use, as well as 
anecdotal concerns about potential bleeding, full blood counts and clotting profiles were 
performed after the first 7 days of supplementation. Values for all participants were within 
expected normal ranges, with no evident effect of PCO as shown in Table 4.1.1 and Table 
4.1.2. 
Table 4.1.1: Effects of placebo and PCO treatments on full blood count. Blood sample analysis was performed 
on Day 7 for each participant. Data are expressed as means and standard deviations (SD). PCO -
proanthocyanidolic oligomers, MCV - Mean Corpuscular Volume, MCH - Mean Cell Haemoglobin, MCHC - 
Mean Corpuscular Haemoglobin Concentration, RDW - Red cell Distribution Width. Statistical analysis: 
Levene’s test for homogeneity of variance with Games-Howell post hoc test (ANOVA). Placebo n=9 and PCO 
n=9. 
  Placebo PCO 
Parameter Reference range Mean (SD) Mean (SD) 
Total leucocyte count 4.00 – 11.00 x 109/L 6.89  (1.83) 7.43  (0.90) 
Neutrophils 2.00 – 7.50 x 109/L 3.83  (1.46) 4.14  (0.84) 
Lymphocytes 1.00 – 4.00 x 109/L 2.56  (0.72) 2.86  (0.38) 
Monocytes 0.00 – 0.80 x 109/L 0.30  (0.15) 0.23  (0.14) 
Eosinophils 0.00 – 0.40 x 109/L 0.18  (0.10) 0.21  (0.05) 
Fibrinogen 2.20 – 5.00 g/L 3.05  (0.50) 3.00  (0.41) 
Platelet count 140 – 420 x 109/L 251  (63.26) 286.33 (41.65) 
Total red cell count 3.70 – 5.30 x 1012/L 4.92  (0.48) 4.83  (0.48) 
Haemoglobin 11.50 – 15.50 g/dL 13.74  (1.22) 13.89  (1.19) 
Haematocrit 0.35 – 0.45 L/L 0.42  (0.03) 0.42  (0.03) 
MCV 81 – 96 fl 85.44  (3.97) 87.44  (7.45) 
MCH 28 – 35pg 28.11  (1.62) 28.78  (3.03) 
MCHC 32 – 37 g/dL 32.78  (0.44) 32.89  (0.78) 
RDW 10 – 15% 13.30  (1.04) 12.87  (1.43) 
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Table 4.1.2: Effects of placebo and PCO treatments on clotting profile. Blood sample analysis was performed 
on Day 7 for each participant. Data are expressed as means and standard deviations (SD). PT - Prothrombin 
time, INR - International Normalized Ratio, aPTT - activated clotting time, PCO - proanthocyanidolic 
oligomers. Statistical analysis: Levene’s test for homogeneity of variance with Games-Howell post hoc test 
(ANOVA). Placebo n=9 and PCO n=9 
  PLACEBO PCO 
Parameter Reference range Mean (SD) Mean (SD) 
PT 11- 13.5 sec  12.54  (1.65) 11.68  (1.19) 
INR 0.9 – 1.3 1.09  (0.11) 1.03  (0.05) 
aPTT 25.4 – 38.4 sec 30.10  (2.83) 30.36  (3.18) 
 
 
4.2 Effects of PCO Treatment on Neutrophil Migration 
 
The assay used for neutrophil chemokinesis is novel. Representative images are presented for 
the placebo- (Figure 4.2.1) and PCO-treated groups (Figure 4.2.2.). In both figures, frames 
A (D0) and C (D14) shows the minimal movement of cells in absence of a chemotactic 
signal, while frames B and D indicate substantially more movement when exposed to an 
fMLP signal. No difference was observed over time or between treatment groups.  
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A B 
C D 
Figure 4.2.1 Representative images of placebo (untreated) neutrophil chemokinesis showing migrational movement of 
unstimulated neutrophils on day 0 (A) and day 14 (C), as well as fMLP-stimulated neutrophils at the same time points (B 
and D). The migrational pathway tracked for the neutrophils is seen by the coloured lines on each image. The blue arrows 
indicate the direction the neutrophils should move towards the chemoattractant added. PCO - proanthocyanidolic oligomers, 
fMLP - N-Formylmethionine-leucyl-phenylalanine. Images taken at 20x magnification. Placebo D0 unstimulated n=6, Placebo 
D0 stimulated n=6, Placebo D14 unstimulated n=9, Placebo D14 stimulated n=9 
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DC 
A B 
Figure 4.2.2 Representative images of PCO treated neutrophil chemokinesis showing migrational movement of 
unstimulated neutrophils on day 0 (A) and day 14 (C), as well as fMLP-stimulated neutrophils at the same time points (B 
and D). The migrational pathway tracked for the neutrophils is seen by the coloured lines on each image. The blue arrows 
indicate the direction the neutrophils should move towards the chemoattractant added. PCO - proanthocyanidolic oligomers, 
fMLP - N-Formylmethionine-leucyl-phenylalanine. Images taken as 20x magnification. PCO D0 unstimulated n=6, PCO D0 
stimulated n=6, PCO D14 unstimulated n=9, PCO D14 stimulated n=9 
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Numerical data obtained by performing analysis of variance (ANOVA) test on the effects of 
chemotaxin stimulation on total and linear distance travelled by neutrophils are presented in 
Figures 4.2.3 and 4.2.4. Findings from this analysis confirm the qualitative results shown 
earlier (Figures 4.2.1 and 4.2.2) and hence the validity of the model. Data indicates that 
fMLP stimulation significantly increased the total (≈60%; ANOVA main effect of 
stimulation, P < 0.05) and linear (≈185%; ANOVA main effect of stimulation, P < 0.05) 
neutrophil distance travelled compared to unstimulated total and linear neutrophil distance 
travelled. Group-specific quantitative results confirmed visual results, with no significant 
treatment or time effect (Table 4.2). 
 
 
Figure 4.2.3 Effect of fMLP stimulation on total distance travelled by neutrophils. Data are expressed as 
means and standard error of means (SEM). Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA). fMLP - 
N-Formylmethionine-leucyl-phenylalanine. Unstimulated n=30, Simulated n=30. 
 
 
 Figure 4.2.4 Effect of fMLP stimulation on linear distance travelled by neutrophils. Data are expressed as 
means and standard error of means. Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA). fMLP - N-
Formylmethionine-leucyl-phenylalanine. Unstimulated n=30, Simulated n=30. 
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Table 4.2 The distance travelled by neutrophil on day 0 (D0) and day 14 (D14) for placebo and PCO treated 
groups under stimulated and unstimulated conditions. Values are expressed as means and standard deviations 
(SD). PCO- proanthocyanidolic oligomers, fMLP- N-Formylmethionine-leucyl-phenylalanine. Statistical 
analysis: Post Hoc Fischer’s LSD test (ANOVA). Placebo D0 unstimulated n=6, Placebo D0 stimulated n=6, 
Placebo D14 unstimulated n=9, Placebo D14 stimulated n=9. PCO D0 unstimulated n=6, PCO D0 stimulated 
n=6, PCO D14 unstimulated n=9, PCO D14 stimulated n=9 
 
 
 
Neutrophil 
chemokinetic 
indicators 
PLACEBO  PCO  
Unstimulated Stimulated Unstimulated Stimulated 
D0 D14 D0 D14 D0 D14 D0 D14 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Total 
Distance 
(um) 
65.08 
(37.30) 
73.26 
(35.46) 
83.32 
(54.66) 
143.21 
(60.77) 
92.64 
(56.14) 
81.24 
(43.68) 
112.90 
(69.78) 
155.78 
(67.11) 
Linear 
distance (um) 
12.67 
(13.93) 
16.61 
(10.470 
26.66 
(16.57) 
53.19 
(29.16) 
13.54 
(10.71) 
13.52 
(42.91) 
35.30 
(25.27) 
42.91 
(29.01) 
 
4.3 Effects of PCO Treatment on Expression of Selected molecular 
Proteins in Neutrophils 
 
The result obtained for CD66b expression in neutrophils is presented in Figure 4.3.1. There 
was no significant difference between treatment groups. The expression of CD66b at day 0 
was not significantly different from that observed at day 14 for both placebo and PCO-treated 
groups, although the average expression was lower for both groups on day 14. Similar effects 
were observed for the expression of adhesion markers ICAM and VCAM in neutrophils as 
shown in Figure 4.3.2 and 4.3.3 respectively. No significant difference was observed 
between treatments even after 14 days interval. The representative flow cytometric panels of 
unstained and multiple stained neutrophil population against CD66b, ICAM and VCAM 
antibodies are shown in Figures 4.3.4 and 4.3.5 which indicate that the markers used are 
expressed and indeed cross the threshold. 
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Figure 4.3.1 Effects of placebo and PCO treatments on expression of CD66b in neutrophils at day 0 (D0) and 
day 14 (D14) of supplementation. Data are expressed as means and standard error of means. MFI - median 
fluorescent intensity in arbitrary units; PCO - proanthocyanidolic oligomers, MFI- Median Fluorescent 
Intensity. Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA). Placebo D0 n=9, PCO D0 n=9, Placebo 
D14 n=9, PCO D14 n=9. 
 
 
 
Figure 4.3.2 Effects of placebo and PCO treatments on expression of ICAM in neutrophils at day 0 (D0) and 
day 14 (D14) of supplementation. Data are expressed as means and standard errors of means. PCO - 
proanthocyanidolic oligomers, MFI - median fluorescent intensity in arbitrary units, ICAM – Intracellular 
Adhesion Molecule. Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA).  Placebo D0 n=9, PCO D0 
n=9, Placebo D14 n=9, PCO D14 n=9. 
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Figure 4.3.3 Effects of placebo and PCO treatments on expression of VCAM in neutrophils at day 0 (D0) and 
day 14 (D14) of supplementation. Data are expressed as means and standard errors of means. MFI - median 
fluorescent intensity in arbitrary units, PCO - proanthocyanidolic oligomers, VCAM – Vascular Adhesion 
Molecule. Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA).  Placebo D0 n=9, PCO D0 n=9, Placebo 
D14 n=9, PCO D14 n=9. 
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Figure 4.3.4 Representative flow cytometric panels showing unstained neutrophil population stained against 
CD66b, ICAM and VCAM antibodies. Vertical lines indicate fluorescence thresholds while unstained 
populations found on the left side of the threshold are indicative of negative staining for the fluorescent labels. 
Placebo D0 n=9, PCO D0 n=9, Placebo D14 n=9, PCO D14 n=9. 
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Figure 4.3.5 Representative flow cytometric panels showing multiple stained neutrophil population stained 
against CD66b, ICAM and VCAM fluorescent antibodies. Vertical lines indicate fluorescence thresholds while 
multiple stained populations found on the right side of the thresholds are indicative of positive staining for the 
fluorescent labels. Placebo D0 n=9, PCO D0 n=9, Placebo D14 n=9, PCO D14 n=9. 
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4.4 Effects of PCO Treatment on Neutrophil Migrational 
Mechanisms 
 
Representative images obtained from the expression of intracellular indicators of neutrophil 
polarisation, ROCK and PI3K, when neutrophils are supplemented with placebo and PCO are 
shown in Figure 4.4.1 and Figure 4.4.2 respectively. From the qualitative data, it seems that 
more co-localization occurs under stimulated conditions. Pixels seem more dispersed in 
images A and C (unstimulated), when compared to B and D (stimulated).  
 
 
 
 
 
D C 
B A 
Figure 4.4.1: Representative images of fixed and stained neutrophils from placebo-supplemented individuals after 
migration. (A) Stained neutrophils on Day 0 that migrated towards RPMI (unstimulated); (B) Stained neutrophils on 
Day 0 that migrated towards the fMLP chemoattractant (stimulated); (C) Stained neutrophils on Day 14 that migrated 
towards RPMI (unstimulated); (D) Stained neutrophils on Day 14 that migrated towards the fMLP chemoattractant 
(stimulated). ROCK stained green colour while PI3K stained red. The two colours seemed to co-localize which is why 
the yellow colour can be seen. Dappi (1:20 dilution) was used and stained the neutrophil nuclei blue. fMLP - N-
Formylmethionine-leucyl-phenylalanine, PI3K – Phosphoinositide 3-Kinase, ROCK- Rho-associated coil-containing 
protein kinase . Images taken at 20x magnification. Placebo D0 n=8, PCO D0 n=8, Placebo D14 n=9, PCO D14 n=9. 
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Upon quantification of the images shown above, both ROCK and PI3K expression were 
highly variable between individuals, as well as over time (Figures 4.4.3 and 4.4.4.). In 
addition, no statistical significant effect on these parameters was evident with PCO treatment 
although there seems to be a deviation in ROCK expression after PCO treatment (PCO day 
14 different from all other conditions). Also, there exists a tendency for an interaction effect 
A B
DC
Figure 4.4.2: Representative images of fixed and stained neutrophils from PCO-supplemented individuals after 
migration. (A) Stained neutrophils on Day 0 that migrated towards RPMI (unstimulated); (B) Stained neutrophils on 
Day 0 that migrated towards the fMLP chemoattractant (stimulated); (C) Stained neutrophils on Day 14 that migrated 
towards RPMI (unstimulated); (D) Stained neutrophils on Day 14 that migrated towards the fMLP chemoattractant 
(stimulated). ROCK stained green colour while PI3K stained red. The two colours seemed to co-localize which is why 
the yellow colour can be seen. Dappi (1:20 dilution) was used and stained the neutrophil nuclei blue. PCO - 
proanthocyanidolic oligomers, fMLP - N-Formylmethionine-leucyl-phenylalanine, PI3K – Phosphoinositide 3-Kinase, 
ROCK- Rho-associated coil-containing protein kinase . Images taken at 20x magnification. Placebo D0 n=8, PCO D0 
n=8, Placebo D14 n=9, PCO D14 n=9. 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 48 
(P=0.06) of treatment, time and fMLP stimulation (Figure 4.4.3).  From the graph, it is 
possible that this effect is due to a different response to fMLP stimulation after 14 days of 
PCO treatment, as the ROCK expression decreased by more than 50% after stimulation.  
 
 
Figure 4.4.3 Expression of PI3K in neutrophils from placebo and active groups under unstimulated and 
stimulated conditions at day 0 (D0) and day 14 (D14).  Data are expressed as means and standard errors of 
means (SEM). PCO - proanthocyanidolic oligomers. PI3K - Phosphoinositide 3-Kinase, MFI-median 
Fluorescent Intensity. Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA). Placebo D0 n=8, PCO D0 
n=8, Placebo D14 n=9, PCO D14 n=9. 
 
 
Figure 4.4.4 Expression of ROCK in neutrophils from placebo and active groups under unstimulated and 
stimulated conditions at day 0 (D0) and day 14 (D14).  Data are expressed as means and standard errors of 
mean (SEM). PCO - proanthocyanidolic oligomers. ROCK - Rho-associated coil-containing protein kinase, 
MFI-median Fluorescent Intensity. Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA). Placebo D0 
n=8, PCO D0 n=8, Placebo D14 n=9, PCO D14 n=9. 
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Furthermore, an aberration in ROCK co-localisation with PI3K was seen in neutrophils 
treated with PCO when compared to that of placebo group as shown in Figure 4.4.5. Also, 
fMLP stimulation significantly (P<0.05) increased the relative portion of ROCK co-
localisation with PI3K as a result of treatments, once again validating the novel model. For 
both D0 groups, as well as D14 PLA, ROCK co-localisation increased by more than 25% 
(although not statistically significantly; (Figure 4.4.6), while in contrast, ROCK co-
localisation in the PCO-treated group on D14 did not change on stimulation. Taken together, 
these data suggest a relatively greater sensitivity to modulation by PCO for ROCK expression 
compared to PI3K, where no differences in total expression or co-localisation was observed 
(Figure 4.4.7).    
 
 
Figure 4.4.5 Effects of fMLP stimulation on co-localization coefficient of ROCK expression in neutrophils. 
ANOVA main effect of treatment, P<0.05 Data are expressed as means and standard errors of mean (SEM). 
Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA) ROCK- Rho-associated coil-containing protein 
kinase, Co-localization coefficient – relative number of co-localizing pixels in ROCK respectively, as compared 
to the total number of pixels above the threshold (PI3K and ROCK combined). Unstimulated n= 34, Stimulated 
n=34. 
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Figure 4.4.6 Co-localization coefficient of ROCK expression in neutrophils from placebo and active groups 
under unstimulated and stimulated conditions at day 0 (D0) and day 14 (D14). Data are expressed as means 
and standard errors of mean (SEM). Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA). ROCK - Rho-
associated coil-containing protein kinase, PCO - proanthocyanidolic oligomers, Co-localization coefficient – 
relative number of co-localizing pixels in ROCK respectively, as compared to the total number of pixels above 
the threshold (PI3K and ROCK combined PCO - proanthocyanidolic oligomers, ROCK - Rho-associated coil-
containing protein kinase, PI3K - Phosphoinositide 3-Kinase. Placebo D0 n=8, PCO D0 n=8, Placebo D14 
n=9, PCO D14 n=9. 
 
 
Figure 4.4.7 Co-localization coefficient of PI3K expression in neutrophils from placebo and active groups 
under unstimulated and stimulated conditions at day 0 (D0) and day 14 (D14). Data are expressed as means 
and standard errors of mean (SEM). Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA). PI3K - 
Phosphoinositide 3-Kinase, PCO - proanthocyanidolic oligomers, ROCK - Rho-associated coil-containing 
protein kinase Co-localization coefficient- relative number of co-localizing pixels in PI3K respectively, as 
compared to the total number of pixels above the threshold (PI3K and ROCK combined). Placebo D0 n=8, 
PCO D0 n=8, Placebo D14 n=9, PCO D14 n=9. 
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4.5 Effect of PCO Treatment on Macrophage Phenotype 
 
The expression of macrophage phenotype markers in neutrophils from treatment groups over 
time are presented in Table 4.5.  No main effect of treatment or over time was seen, although 
it should be noted that both intra- and inter-individual variations were quite large.  
Table 4.5 Effects of placebo and PCO on macrophage markers in neutrophils at day 0 (D0) and day 14 (D14) 
after treatments. Data are expressed as means and standard deviation (SD). MFI-Median Fluorescent Intensity 
PCO - proanthocyanidolic oligomers, MPO –Myeloperoxidase, HLA-DR – Human leukocyte antigen D, IL-10 
Interleukin-10. Statistical analysis: LSD test (ANOVA). Placebo D0 n=9, PCO D0 n=9, Placebo D14 n=9, PCO 
D14 n=9. 
 
 
Macrophage 
Phenotypic 
Markers 
 
Placebo Do 
 
Placebo D14 
 
PCO D0 
 
PCO D14 
 
Mean (SD) 
 
 
Mean (SD) 
 
 
Mean (SD) 
 
 
Mean (SD) 
 
 
CD86 MFI 
 
1071.67  
(493.78) 
 
1344.89   
(468.68) 
 
1086.44  
(436.61) 
 
1284.226 
 (84.83) 
 
HLA-DR 
MFI 
 
1144.67  
(602.05) 
 
1513.33   
(607.96) 
 
827.33 
(402.60) 
 
1131.33 
(691.58) 
 
CD274 
MFI 
 
601.44 
(370.66) 
 
669.67  
(405.02) 
 
557.56  
(331.41) 
 
450.33 
(198.01) 
 
MPO 
MFI 
 
1940.44  
 (1426.93) 
 
1819.00  
 (1813.36) 
 
1838.67 
 (1020.85) 
 
1868.89 
(1658.63) 
 
CD206 
MFI 
 
1895.56  
(1620.96) 
 
2027.22  
(1204.05) 
 
1474.11  
(1408.42) 
 
1440.44 
(953.22) 
 
CD163 
MFI 
 
464.56   
(186.56) 
 
543.11  
(186.99) 
 
487.33  
(219.20) 
 
488.11 
(194.85) 
 
IL-10 
MFI 
 
256.67 
 (170.83) 
 
195.67  
(66.09) 
 
178.00  
(46.78) 
 
199.44 
(97.42) 
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Figures 4.5.1 and 4.5.2 illustrate representative flow cytometric panels showing unstained 
and multiple stained macrophage population. The data indicates that the markers used are 
thus expressed and indeed cross the threshold. 
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Figure 4.5.1 Representative flow cytometric panels showing unstained macrophage population stained 
against M1 (CD86, HLA-DR, CD274, MPO) and M2 (CD206, CD163, IL-10) fluorescent antibodies. Vertical 
lines indicate fluorescence thresholds while unstained populations found on the left side of the thresholds are 
indicative of negative staining for the fluorescent labels. Placebo D0 n=9, PCO D0 n=9, Placebo D14 n=9, 
PCO D14 n=9 
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Figure 4.5.2 Representative flow cytometric panels showing multiple stained macrophage population stained 
against M1 (CD86, HLA-DR, CD274, MPO) and M2 (CD206, CD163, IL-10) fluorescent antibodies. Vertical 
lines indicate fluorescence thresholds while multiple stained populations found on the right side of the 
thresholds are indicative of positive staining for the fluorescent labels. Placebo D0 n=9, PCO D0 n=9, Placebo 
D14 n=9, PCO D14 n=9 
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Interestingly, for both CD274 and MPO – both pro-inflammatory indicators – the D0 vs D14 
values were inversely correlated in the PCO-treated group only (Figures 4.5.3 and 4.5.4). 
Figure 4.5.3 and Figure 4.5.4 The PCO group showed a significant Trendline over time that 
was not evident in the Placebo group. 
 
 
Figure 4.5.3 Relationship between CD274 expression for placebo and PCO treatments with time. 
Statistical analysis: Post Hoc Fischer’s LSD test (ANOVA) and Pearson P-test. MFI-Median Fluorescent 
Intensity. Placebo D0 n=9, PCO D0 n=9, Placebo D14 n=9, PCO D14 n=9 
 
 
Figure 4.5.4 Relationship between MPO expression for placebo and PCO treatments with time. MFI-
Median Fluorescent Intensity, MPO- Myeloperoxidase. Statistical analysis: Post Hoc Fischer’s LSD 
test (ANOVA) and Pearson P-test.  Placebo D0 n=9, PCO D0 n=9, Placebo D14 n=9, PCO D14 n=9 
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5. CHAPTER 5: DISCUSSION 
 
Good laboratory and clinical practice guidelines prescribe very specific procedures for the 
testing of an experimental pharmaceutical drug. After initial proof of concept, potential 
mechanisms of action of the drug are probed in vitro, followed by safety and efficacy studies 
using suitable animal models. Then, before the drug can be tested in patients with the relevant 
pathology, the drug is first assessed for effects and/or safety in the absence of disease, in a 
normally healthy population. The study described in this thesis, present data from such a 
human trial. 
The population investigated in this study – a young, normally healthy population – is not 
expected to be in a pro-inflammatory state or have high level of cumulative oxidative stress, 
especially at rest, when blood samples were obtained. Thus, supplementation with an anti-
oxidant or anti-inflammatory therapeutic product is unlikely to show major effects in this 
population. However, despite low statistical power due to large inter- and intra-individual 
variability in parameters assessed, findings from the study have successfully identified some 
therapeutic targets that are sufficiently sensitive to provide new information on the 
mechanisms by which grape-derived polyphenols achieve their previously reported anti-
inflammatory effects. 
In this chapter, we will first discuss the results obtained from the evaluation of the safety of 
the grape seed product employed in this study in terms of the risk for bleeding tendencies and 
general haematology. Next, we will discuss the data pertaining to the potential mechanisms 
of action of the drug that were elucidated using a novel technique.  
 
5.1 Consumer safety 
 
A direct link between the induction of blood coagulation and the activation of inflammatory 
processes was reported some years ago (Levi et al., 2004). This suggests that these processes 
are at least to some extent linked, as they both play pivotal roles in the pathogenesis of 
vascular disease (Levi et al., 2004).  Thus, it would be difficult to separate these two 
processes, as many coagulation disorders are associated with inflammatory diseases and vice 
versa. The two processes are thought to exist in continuum and within three stages; namely, 
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blood coagulation activation, a decrease in natural anti-coagulant activity and concomitant 
decrease in fibrinolytic activity. Anti-thrombotic endothelial normal functions are also 
influenced by inflammation as a loss of homeostasis in the normal coagulation process does 
not only lead to a stressed thrombotic condition, but also leaves the inflammatory process in a 
perpetual loop  (D’Angelo, 2015).  
Also, more recently, anecdotal accounts associating the use of herbal and/or natural 
supplements with bleeding tendencies have been reported (personal communications between 
Prof Smith and consumers). To our knowledge, no literature exist on potential effects of PCO 
on hemostasis. We found only one study investigating product safety. In this study, a clinical 
trial involving 66 volunteers with moderate or marked breast induration at a mean of 10.8 
year post-radiation for early breast cancer, subjects were given 100mg grape seed 
proanthocyanidin extract (GSPE) three times a day for 6 months. Although no statically 
significant results were reported in terms of anti-cancer effects, no adverse effects were 
reported after this relatively prolonged supplementation period (Brooker et al., 2006). More 
recent work in animals supplemented with PCO for a period of up to two weeks (Myburgh et 
al., 2012), (Kruger et al., 2014), supports this report of consumer safety, as no adverse effects 
of PCO supplementation was reported. Although a recent case study involving a 49-year old 
Caucasian male described the patient presenting with recurrent nausea and vomiting after 
GSPE consumption, no clinical cause of these symptoms were found after a thorough medical 
workup. Thus, although these symptoms were reported to subside once supplementation was 
discontinued (Berry et al., 2016), it cannot be conclusively ascribed to the supplement used. 
Despite these mostly positive reports, it is probably advisable to err on the side of caution 
especially in the case of natural products, which often consist of multiple active ingredients. 
The doses and duration of supplementation are also important factors to consider in this 
context. 
Therefore, in the current study, both the functionality of the intrinsic and extrinsic clotting 
pathways (see Figure 6.1) were assessed after 7 days of PCO or placebo supplementation. . 
The Prothrombin time (PT) measures the integrity of the extrinsic system (clotting factors X, 
VII, V, II (Prothrombin) and I (fibrinogen)) as well as considering factors that are common in 
both systems, while the partial thromboplastin time (PTT) which measures the integrity of the 
intrinsic system (Factors XII, XI, VIII, and IX), (Hoffbrand et al., 2011). All participants’ 
fibrinogen levels and Prothrombin time were within normal ranges. In addition, an activated 
partial thromboplastin time (aPTT) test similarly showed no abnormality. Thus, we suggest 
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that blood coagulation was not adversely affected by the consumption of PCO, at least not to 
an extent that reached clinical significance within the 7-day period assessed. However, 
conclusions on long-term effects should not be extrapolated from these data. Given the many 
positive effects reported for grape-derived products in the literature, long-term safety and 
drug-interaction studies are warranted. 
 
 
Figure 6.1: The Clotting Cascade (Self Illustrated) 
Furthermore, the full blood counts for all individuals (both placebo and PCO groups) 
remained unchanged and within the normal range. Generally, changes in red blood cell 
indices – such as microcytosis or an increased red cell distribution width (Allen et al., 2010) 
– would indicate drug-associated abnormalities in nutrient absorption or even intravascular 
bleeding (Isik et al., 2012). Also, the latter would often be accompanied by lower platelet 
counts. No evidence of such adverse effects was reflected in haematology data in the current 
study.  Similarly, the normal and unaffected white blood cell parameters suggests absence of 
cell proliferation in circulation, which could be indicative of intolerance to or toxicity of the 
drug/supplement (Guilford et al., 2011). Based on these findings, is we conclude that the 
PCO supplement employed in this study was safe to consume. 
However, at this point, for the sake of being thorough, it is important to note that hemostasis 
comprises two mechanisms (apart from local vasoconstriction), namely platelet plug 
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formation and coagulation. Data presented here pertains to coagulation only. In order to 
assess platelet functionality, a bleeding time test is commonly performed. This entails making 
a 1mm deep, 10mm long cut into the participant skin, to assess the time taken for a platelet 
plug to form. Since this test requires some skill and results in permanent scarring on the skin, 
we decided that the inclusion of this specific test could not be ethically justified.   
Returning attention to the links between coagulation and inflammation, it has also been 
reported that tissue factor plays an important role in inflammation, as the extracellular 
coagulation signalling pathway is able to trigger an intracellular signalling response. The 
downstream coagulation factors (VIIa, Xa and thrombin) are pro-inflammatory and are, 
therefore, capable of causing an inflammatory state by inducing the protease-activated 
receptors (PAR) found on the surface of cells. PAR activating peptides elicit a broad 
spectrum of inflammation, which is consistent with the notion of coagulation-dependent 
inflammation. This activation induces the expression of various inflammatory molecules such 
as TNF-α, interleukins, and adhesion molecules (ICAM-1 and VCAM-1) (Hoffbrand et al., 
2011). The adhesion molecules mediate the adhesion of lymphocytes to the vascular 
endothelium and may also function in their signalling transduction. When cytokines are 
activated, ICAM-1 and VCAM-1 expression is upregulated in this pro-inflammatory state and 
thus lead the risk of atherosclerosis development. However, in the current study, no effect of 
PCO was evident on either ICAM-1 or VCAM-1 (more on this later), supporting our 
conclusion on its safety, at least in the context of coagulation.   
 
5.2 Development of novel neutrophil migration model 
 
Normally, in vitro neutrophil migration is assessed using a Dunn chamber (Sapey et al., 
2011), (Sapey et al., 2014) or microfluidics systems (Irimia et al., 2006), (Irimia, 2010), 
while videomicroscopy in commonly used for in vivo investigations (Germain et al., 2008). 
However, none of these models allow for immunostaining of cells at the endpoint, as they are 
all closed systems. Thus, mechanisms cannot be directly linked to functional outcome. Thus, 
a novel migration assay was developed to overcome this limitation. Eight-well chamber 
slides were employed, enabling both live cell tracking and post-fixation immunocytochemical 
staining on the same sample. Neutrophil chemokinesis results reported here, consistently 
indicate the success of this model and the appropriateness of using fMLP as chemotaxin. To 
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our knowledge, this technique has not been reported previously. Since PCO had no effect on 
neutrophil chemokinesis in the healthy population in this study, these results to not inform 
about the sensitivity of the model in indicating the therapeutic efficacy of anti-inflammatory 
products. However, the consistent aberration in ROCK-related parameters in the PCO-treated 
group, suggests that this model may indeed be sufficiently sensitive to elucidate molecular 
targets of such products. A follow-up study in a population with a more inflammatory 
phenotype at baseline may provide more information.  
Focussing on the actual data generated on potential effects of PCO in this model, as 
mentioned, no effect on migration was observed for PCO treatment. Although several reports 
of positive effects of polyphenols and PCO on inflammation exist (Kruger et al., 2012) 
(Myburgh et al., 2012), there is relative paucity of information on neutrophil migration and 
chemokinesis after in vivo PCO supplementation. In contrast to our current results, an 
improved neutrophil directional accuracy (total and linear distance) was reported after in vitro 
PCO treatment of cells isolated from an aged population (Petersen et al., 2016). However, 
these differences in results can be attributed to different effects in vivo and in vitro. Firstly, 
neutrophils which are isolated and then treated with PCO are exposed to a more controlled 
environment (in terms of dose of PCO, time of exposure and potential confounding factors, 
which allows direct effect of PCO to be seen. Importantly, in an in vitro model, assuming 
proper laboratory technique and functional equipment, the differences between repeats of any 
experiment should be fairly small. In contrast, in in vivo studies, the net effects of PCO is 
assessed after the supplement has been metabolised – a process which depends on the 
inherent metabolic rate of each individual assessed. Furthermore, the neutrophil as the first 
line of defence is arguably the most excitable immune cell, so that it may be activated for 
various reasons unrelated to the study intervention. Thus, inter- and intra-individual 
variations may mask effects, adding to the complexity of interpreting data from a model such 
as the one employed here. This variability was indeed noted in both the PCO group and 
placebo group, as well as for both groups over time. In order to better understand the 
variation, a reliability value calculation was performed on both total and linear distance, both 
between individuals and for the same individuals over time. Briefly, reliability was calculated 
as follows: 
 
The inter-individual repeatability value was 0.61 and 0.43 for total and linear distance 
respectively, and the intra-individual repeatability value 0.39 and 0.57. This implies that 
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inter-person variation contributed to 61% and 43% of the variability in current data. 
Statistical power could therefore be improved by addition of more subjects. A subsequent 
power analysis indicated that more than 80 subjects would be required to provide sufficient 
statistical power – a number that is not feasible, given the cost of analyses. Furthermore, 
given the fact that day-to-day variation is shown to contribute 39% and 57% of variability for 
total and linear distance respectively, even data from a bigger group is likely to be complex to 
interpret in a longitudinal study design. Rather, we recommend that in vivo studies should 
either be of cross-sectional design – i.e. focus on acute effects on potential molecular targets 
– or that a very controlled clinical trial should be conducted, during which not only food 
intake, but also exposure to potential antigens, can be limited. Alternatively, a population 
with a poorer inflammatory profile may be more ideal to illustrate anti-inflammatory effects. 
Although no significant effect was seen in terms of neutrophil movement parameters, given 
this variability, it does not exclude molecular effect. This is discussed in the next sections. 
 
5.3 Potential Molecular Mechanisms affected 
 
Plasma levels of soluble adhesion molecules is the more commonly used protocol for 
assessing cellular adhesion dynamics in the recent literature. An obvious limitation of this 
approach is that the source of adhesion molecules in plasma cannot be deduced from this, 
since the shedding of expression markers can be attributed to various cell types. Very little 
literature is available on neutrophil expression of adhesion molecules. One study 
investigating the ability of IL-4 to induce adherence in neutrophils included assessment of 
cellular expression of VCAM-1 and ICAM-1 in neutrophils after the stimulation. They found 
IL-4 had no effect on neutrophil adherence and that only VCAM-1 expression was induced 
but not at such a rate that it affected the expression of other adhesion molecules (Schleimer et 
al., 1992) .Furthermore, we could find no information in literature on the cellular expression 
of adhesion molecules, such as CD66b, ICAM-1 or VCAM-1, in neutrophils under 
unstimulated conditions (i.e. basal expression). Hence, we assessed the expression of these 
surface and cytoplasmic adhesion molecules in neutrophils, to determine the cell-specific 
effects of PCO supplementation in healthy individuals. Results obtained from the present 
study indicated that PCO has no effect on intracellular expression of CD66b, ICAM-1 or 
VCAM-1. Although one would expect an anti-inflammatory product to exhibit significant 
modulatory effects on adhesion, our result is actually supported by the data reported by 
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Schleimer et al. (1992), since they also found no change after treatment with IL-4, which is 
also a known anti-inflammatory modality (Boyle et al., 1999).  In contrast, an in vitro study 
on the effects of red grape polyphenols on some of these markers (Noratto et al., 2011), 
reported decreased ICAM-1 protein and gene expression. However, this effect of the 
polyphenols were only evident after stimulation of the (HUVEC) cells to lipopolysaccharide 
(LPS), which is a known up-regulator of these adhesion molecules (Thornhill et al., 1990), 
(Briscoe et al., 1992), (Huang et al., 1996). Together, these results suggest that assessment of 
anti-inflammatory effects under basal conditions is not reflected by cellular adhesion protein 
expression. 
However, criticism against the use of soluble adhesion molecule levels have also been 
published. For example, although upregulated soluble adhesion molecule levels had been 
reported in extreme inflammatory models, such as Gave opthlamopathy and thyroid disease 
(Heufelder et al., 1993), as well as in rheumatoid arthritis (Cush et al., 1993), soluble 
adhesion molecule shifts were not evident at the point of relapse in Wegener’s 
granulomatosis – a somewhat milder inflammatory condition (Stegeman et al., 1994). Thus, 
we propose that the best model to use would be an in vivo model of supplementation, with 
effects of supplementation assessed in a cell-specific manner rather than assessment of 
soluble adhesion molecules. However, it would be important to conduct these assessments 
after an in vitro application of an appropriate pro-inflammatory stimulus such as LPS, in 
cases where only mild or low grade inflammation exist. A more comprehensive study, 
assessing both soluble and neutrophil-associated adhesion molecule levels, both under basal 
and stimulated conditions, could shed more light on this issue.  
Nevertheless, the data generated in this study may provide a basis for the establishment of a 
reference range for CD66B, ICAM-1 and VCAM-1 expression for this technique used in 
normal, healthy neutrophil populations, as assessed by flow cytometry. Also, it provides 
evidence of large variations not just between participants, but also intra-individual, day-to-
day variations at basal level under unstimulated conditions, which may explain why the 
positive effects of PCO reported from more controlled study designs and models, have not 
been duplicated in the current study. 
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5.4 Neutrophil polarization  
 
As previously explained, neutrophil polarization is a process that causes neutrophils to 
undergo a mechanical shape change (elongation) which demonstrate a clear leading and tail 
end of the cell (Shi et al., 2009). To understand the possible mechanisms involved within the 
leading and trailing edge, the expressions of PI3K and ROCK in neutrophils were 
investigated.   
Similar to the results for adhesion molecule expression, neutrophil PI3K expression was 
highly variable between neutrophils in any single sample, between individuals, and also over 
time – these variations were also independent of stimulation. For example, in the placebo 
group, median fluorescence intensity after fMLP stimulation was 0.89 on day 0, but almost 
double on day 14, at 1.61. While the reason for this similar trend in all groups are not clear, it 
is of interest that in the PCO group, this increase over time seemed to be attenuated, although 
not reaching statistical significance. Thus, PCO could potentially act as a modulator for PI3K, 
thereby preventing over-activation of inflammation. PI3K is known to be found in the leading 
edge and also responsible for the synthesis of PIP3 (Billadeau, 2008), (Heit et al., 2008). 
PIP3 accumulation in the leading edge is seen as an early and noticeable occurrence once cell 
polarization is initiated as a result of chemoattractant stimulation (Servant et al., 2000) 
(Hawkins et al., 2010). However, the over production of PIP3 in the rear has been linked to a 
disruption of the PIP3-polarity gradient (Mondal et al., 2012) and thus affecting neutrophil 
directionality. Our data may thus suggest that in this context, PCO – by preventing over-
activation of PI3K – could stabilise the expression of PIP3 in the rear of the cell, thereby 
improving directional accuracy. However, given the large variability of this parameter in an 
in vivo model, this potential mechanism should be investigated in more detail in a more 
controlled in vitro experiment, before firm conclusions may be made. 
Our interpretation above, which suggests that PCO may have its effect by separating 
localisation sites of PI3K (to the front) and ROCK (to the rear) in a migrating cell, is 
supported by ROCK expression data. As for PI3K, ROCK expression was once again 
variable, but also showed similar increases over time, again under both stimulated and 
unstimulated conditions. Again, as reported for PI3K, the only disturbance in this trend was 
seen in the PCO stimulated group, which showed a ≈25% decrease in median fluorescent 
intensity from 0.44 MFI on day 0 to 0.33 on day 14 – unlike the PI3K result, which lacked 
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statistical significance, ROCK expression showed a more significant tendency for treatment-
time-stimulation interaction.   
In terms of the literature on changes in ROCK expression, a decrease has been linked to 
increased recruitment and migration of neutrophils (Vemula et al., 2010). In contrast, the loss 
of ROCK has been associated with neutrophil tail retraction defects (Pestonjamasp et al., 
2006), (Worthylake et al., 2001). This suggests that an optimal balance in ROCK expression 
is required for optimal migration. We suggest that PCO may act as such an “optimising 
modulator” of ROCK. This is vital to the entire neutrophil migratory mechanism, as ROCK is 
known to regulate PTEN whose role is to dephosphorylate PIP3 to PIP2 and maintain the 
anterior-posterior PIP3 gradient (Mondal et al., 2012), which is vital for maintaining 
directional accuracy (Billadeau, 2008), (Heit et al., 2008). The amount of PIP3 as well as the 
localization within the cell is positively associated with neutrophil migration and the 
recruitment of neutrophils (Vanhaesebroeck et al., 2001), (Hawkins et al., 2006). Our data, 
together with the known anti-inflammatory effect of PCO from previous studies, suggests 
that PTEN could also be modulated and could be implicated of as potential mechanism of 
action for PCO. An assessment of all these parameters simultaneously will further elucidate 
PCO effects on this particular mechanism. However, it is clear from the literature that this 
process is highly complex and extremely sensitive to maintain. 
More interesting facts in support of our interpretation of ROCK and PI3K expression 
modulation by PCO, came to light when, in addition to expression levels, co-localisation of 
PI3K and ROCK was assessed.  
Firstly, current results suggest that a greater extent of co-localization of PI3K and ROCK 
may occur under stimulated conditions than in unstimulated conditions, with relative ROCK 
co-localisation to PI3K more significantly increased (≈25%, P<0.05) than relative PI3K co-
localisation with ROCK. As no literature is available on PI3K and ROCK expression on 
actively migrating neutrophils, placing our results (obtained using our novel approach), into 
context proved challenging. Nevertheless, this result in in line with our interpretation of the 
data on adhesion molecules – i.e. that the effects of PCO should be studied only after 
stimulation.  
Secondly, PCO treatment seemed to limit the increase in ROCK-PI3K co-localisation after 
stimulation, with ROCK seemingly the more sensitive target, as no change in total expression 
and/or co-localization of PI3K with ROCK was seen. This result importantly supports our 
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interpretation that PCO may not necessarily affect total ROCK or PI3K expression levels, but 
may rather optimise the sites in the cell where these are localised. The decrease in ROCK 
localisation with PI3K may indeed point towards a PCO-associated polarisation of the cell to 
have ROCK focused in the rear and PI3K focused in the leading edge of the cell.  
Another consideration in data interpretation – especially given the illustrated importance of 
stimulation – is the timing of assessments after fMLP stimulation. In the current study, 
assessments were made at a time point 40 minutes after stimulation. In the literature, PTEN – 
which functions in the rear of the cell in association with ROCK – was demonstrated to be 
focused in the rear of murine neutrophils in less than 3 minutes after stimulation, with the 
effect of stimulation subsiding somewhat by 5 minutes, when multiple pseudopod formation 
was evident (Subramanian et al., 2007). Thus, our results on co-localisation suggests firstly 
that although early timepoints illustrates the initiation of migration, the role players in cell 
polarisation can still be effectively investigated at a much later time point. This fact enables 
the design of studies assessing both chemokinesis and mechanisms for chemokinesis in the 
same cells – validating our approach. Secondly, current data indicates that the effect of PCO 
was maintained at least for 40 minutes after stimulation. A follow-up study using our novel 
model, but incorporating more frequent time points, may be useful to fully elucidate not only 
effects of PCO, but also the time courses involved in migratory mechanisms, especially under 
conditions of sustained stimulation.  
On a more clinical note, our results also support previous work by our group in the context of 
muscle injury. ROCK is associated with limiting excessive neutrophil recruitment (Vemula et 
al., 2010) and we have previously shown PCO supplementation to decrease neutrophil 
recruitment towards site of injury after experimental contusion damage to skeletal muscle, 
which resulted in less secondary damage (Smith et al., 2008) (Myburgh et al., 2012) (Kruger 
et al., 2014). Our data thus suggests that PCO-associated optimisation of ROCK localisation 
relative to PI3K, may be the mechanism through which this in vivo result was achieved. 
 
5.5 Macrophage phenotype 
 
Apart from neutrophils, macrophages also have an important role to play in the inflammatory 
process. They play a direct role as phagocytes, and more relevant to this thesis, macrophages 
are known to exist within two phenotypes (M1 and M2) and secrete a variety of chemokines, 
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each befitting their own observable characteristics (Mia et al., 2014) – these factors may 
affect neutrophil migration and differ between macrophage phenotypes (Mia et al., 2014). As 
mentioned in the literature review, phenotype shifts after an intervention is most often 
determined in response to a stimulus (Tan et al., 2016). However, apart from the fact that 
such an experimental approach would be financially unfeasible, the aim in the current study 
was not to determine whether immune response is altered in reaction to a challenge; rather, 
the aim was to determine whether basal phenotype profiles would be adapted in response to 
PCO. This is due to previous studies performed by our group (rat models) that demonstrated a 
basal phenotypic shift after PCO consumption with the M2 phenotype predominating 
(Myburgh et al., 2012). An earlier phenotypic switch from M1 macrophages to M2 
macrophages is a desired effect, not only because M2 macrophages are known to possess 
anti-inflammatory properties, but also because they cannot cross the endothelial membranes 
(Arnold et al., 2007). This in turn assists in faster clearance of inflammation (Mia et al., 
2014).  
Current data indicates large variations between individuals and intra-individual day-to-day 
variations with no apparent effect of PCO. There are a few explanations for this: Firstly, PCO 
could have no effect on target macrophages, although this is unlikely, given the reports of a 
phenotype change after supplementation in rats. Secondly, the population used could not be 
suitable or sensitive enough to see a desired effect. This is likely, since a healthy, young 
population are at relatively low risk for low grade inflammation in the absence of a stimulus. 
Thirdly, no stimulus was used to induce a phenotype switch as discussed previously. Again, 
perhaps a more severe model, e.g. arthritis or advanced age, would enable interpretation on a 
potential PCO-induced phenotype switch towards a relatively more anti-inflammatory profile. 
In support of this, during disease progression of atherosclerosis, the levels and intensities of 
various signals in the microenvironment have been reported to cause macrophage phenotypic 
marker expressions to vary (Leitinger et al., 2013), (Geissmann et al., 2010)  This offers a 
more plausible explanation for the variance seen within this data set, especially for the basal 
levels captured. 
Interestingly, a significant inverse correlation existed between D0 and D14 macrophage 
expression levels of the M1 markers CD274 and MPO within the PCO group only. This 
suggests that PCO could possess the potential of being able to modulate M1 macrophage 
phenotype; thus, being effectively able to decrease relatively higher expression levels while 
increasing relatively lower levels. This was seen at basal levels and barring stimulus, which is 
Stellenbosch University  https://scholar.sun.ac.za
 68 
the first proof of a direct effect of PCO on human macrophages. Although literature has 
shown that mild intervention of antioxidant treatment can induce phenotypic shift of 
macrophages under pro-inflammatory conditions (Myburgh et al., 2012), this study offers a 
novel approach by including basal level expression of macrophage phenotypes under 
unstimulated conditions. Given the CD274 and MPO data, it illustrates that these markers 
may be deemed sensitive enough to provide proof of a therapeutic anti-inflammatory effect.  
 Both CD274 and MPO are known to be M1 markers and are able to secrete pro-
inflammatory cytokines as well as ROS. In excess, ROS can be extremely detrimental to the 
immune cell itself (Tan et al., 2016). Hence this finding being of importance, as it assist in 
the modulation of oxidative stress. In support of MPO being modulated in rats, manipulation 
of this phenotype shift has been proposed as therapeutic avenue and has been investigated to 
some extent (Kruger et al., 2012). Here we demonstrate that PCO can modulate MPO at basal 
levels in humans and that a direct effect is seen. The fact that this inverse correlation was not 
present in the placebo group, excludes the possibility that these correlations were as result of 
normal daily variations in immune activation.  
 
5.6 Conclusions and recommendations 
 
In conclusion, we have developed a protocol for simultaneous assessment of neutrophil 
chemokinetic movement toward a chemotaxin and the cellular role players orchestrating this 
highly complex, synchronised event. This novel model was validated in terms of sensitivity 
and choice of chemotaxin, by the significant increase in the co-localization of ROCK with 
PI3K after fMLP stimulation. 
In terms of the supplement investigated, data indicates that in the absence of extreme pro-
inflammatory conditions in vivo, experimental stimulation of isolated neutrophils is required 
to accurately reflect effects of supplements or anti-inflammatory modalities. Secondly, we 
have identified molecular targets of PCO, namely the PI3K-PTEN-ROCK system. 
Furthermore, result indicate that rather than hugely affecting actual expression of these 
proteins involved in cell polarisation, PCO may optimise the location of these molecules 
within the activated cell, to prevent opposing functions of different role players from 
compromising the front-rear synchronisation required for optimal cell movement.  
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Our results are thus in line with our hypothesis. Given the requirement for stimulation and the 
highly variable nature of the parameters in an in vivo context, we propose that mechanistic 
studies be limited to in vitro models. Alternatively, more extreme models of inflammation – 
such as aged populations or those suffering from inflammatory disease – may be more 
suitable to illustrate PCO-induced anti-inflammatory effects over and above the normal 
variation.   
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7. ADDENDUMS 
 
Addendum A: SOP FOR PHLEBOTOMY 
 Drawing blood  
 Make sure the working area is quiet, clean and well-lit 
 Assemble the supplies (Blood collection tubes that have not expired, a tourniquet / 
band, cotton balls, adhesive tape and alcohol wipes) 
 Select the appropriate needle (10ml needle) 
 Bring patient into the exercise physiology lab and allow them to have a seat on the 
bed. 
 You or the patient can decide which arm to draw blood from. 
 Tie the tourniquet around the patient’s arm about 7.5-10cm from the venepuncture 
site 
 The patient needs to form a tight fist to expose the vein at the antecubital area 
 Trace patients veins with index finger and tap the vein to encourage dilation 
 The antecubital area is wiped clean with a alcohol wipe 
 Allow 30sec for disinfected are to dry and avoid the sting of the needle. 
 Thread the needle into the holder 
 Tap any tubes the contain additives to dislodge the additives from the walls of the 
tubes 
 Insert the blood collection tubes into the holder. 
 Grasp your patient’s arm, your thumb should pull skin 2.5-5cm below the 
puncture site 
 Line up the needle with the vein 
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 Insert needle into the vein, push the collection tube toward the holder until the butt 
end of the needle pierces the stopper on the tube. Tube needs to be below puncture 
site. 
 Allow tube to fill, and remove tourniquet as soon as blood flow into tube is 
adequate. 
 Remove tube from holder and mix the contents if tube contains additives, by 
inverting the tube 5-8 times. Do not shake vigorously. 
 Fill the remaining tubes. 
 Ask patient to open his or her hand, place cotton balls over puncture site and close 
with adhesive tape. Apply pressure. 
 4 x 5ml sample is drawn from antecubital area of the arm with a sterile 10ml 
needle. 
 2 x 5ml blood anti-coagulated in sodium heparin tube (neutrophil 
migration assay and IHC) 
 2 x 5ml EDTA (for macrophage isolation) 
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Addendum B: SOP FOR MONOCYTE ISOLATION 
Isolation of Human Monocytes by Double Gradient Centrifugation (Article from JoVE) 
To facilitate balancing of the centrifuge, it is recommended to process two whole blood 
samples in parallel. However, take care to use separate materials for each donor and not 
to mix the cells. Round about 7.5x105 monocytes are obtained from 4 ml of EDTA 
peripheral blood. 
Isolation from donor whole blood 
 Carefully disinfect the EDTA vacutainers containing the peripheral whole blood and 
transfer the contents to sterile plastic tubes. Do not mix blood from different donors. 
 For 2 EDTA vacutainers (8 ml blood) fill two 15 ml tubes with 3 ml 
Ficoll/Histopaque solution (1.077 g/ml). The Ficoll should be at room temperature for 
the preparation. 
 For 4 EDTA vacutainers (16 ml blood) fill two 15 ml tubes with 6 ml 
Ficoll/Histopaque etc.  
 Layer 3-6 ml whole blood on top of the Ficoll solution for the first density gradient. 
Be careful to do this slowly and carefully in order to prevent mixing both layers. 
 Note: Maintain Ficoll:blood ratio at 1:1-2 and Defrost FBS 
 Centrifuge at 400 x g without brake for 30 min at room temperature. 
 For each gradient collect the white ring of peripheral blood mononuclear cells 
(PBMCs) which is located between the two phases with a plastic Pasteur pipette and 
transfer to a 15 ml tube. 
 Fill each tube with 1 mM PBS-EDTA (1x PBS and 0.5 M EDTA) up to 12 ml in total. 
 Centrifuge at 300 x g for 10 min without brake at room temperature. 
 Aspirate supernatant and wash pellet again with 12 ml PBS-EDTA. 
 For each donor pool the pellets in 6 ml RPMI-1640 without phenol red + 10% FBS. 
 
 Prepare the iso-osmotic Percoll solution for the second density gradient: For two 
donors mix 6.939 ml Percoll solution (density: 1.131 g/ml) in a 15 ml tube with 0.561 
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ml 10x PBS. Then transfer 6.9 ml of this solution to a new 15 ml tube and add 8.1 ml 
RPMI-1640 with phenol red + 10% FBS to obtain a 46% iso-osmotic Percoll solution. 
The Percoll should be at room temperature for the preparation. 
 For each donor transfer 7ml of the prepared Percoll solution to a 15 ml tube and layer 
the PBMC solution prepared in step 11.  on top of the Percoll solution. Be careful to 
do this very slowly and carefully, both layers tend to mix easily. If done correctly the 
two phases can be distinguished due to their difference in colour. 
 Centrifuge at 550 x g without brake for 30 min at room temperature. 
 For each gradient collect the white ring of monocytes which is located between the 
two phases with a plastic Pasteur pipette and transfer to a 15 ml tube. 
 Fill each tube with PBS-EDTA up to the 14 ml mark. 
 Centrifuge at 400 x g for 10 min without brake at room temperature. 
 Aspirate the supernatant and resuspend in 1ml cytofix/cytoperm  
 Leave in fridge at 4°C for 20min 
 Centrifuge 4°C, 5min at 400xg 
 Remove supernatant and resuspend in 1ml cytoperm/wash. X2 
 Remove supernatant and resuspend in 1ml plain PBS 
 Aliquot 480ul into two different eppi’s (unstained and multiple stained) add the 
difference in PBS to make up 1ml 
 Switch lights off in the hood. Add all the antibodies, 5ul CD206, 5ul CD274, 5ul 
CD153, 20ul CD86, 5ul IL-10, 5ul HD-LA, 20ul MPO to multiple stained eppi and 
65ul PBS in unstained eppi. 
 Close with tinfoil and place in incubator for 10min 
 Centrifuge 1600rpm for 5min 
 Resuspend in 400ul PBS and store in fridge at 4°C overnight 
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Addendum C: SOP FOR NEUTROPHIL ISOLATION FOR FLOW 
CYTOMETRY  
 2ml Histopaque1077(room temperature) is pipette into a 15ml falcon tube and then 
double volume (4ml) of anticoagulant added blood was carefully poured on this 
Histopaque layer down the side of each tube. 
 Tubes are transferred to the centrifuge machine with swinging rotar and are spun at 
speed of 652xg for 30 minutes at 21°C, 1800rpm. 
* Four different layers of blood are formed* 
 Sediment containing neutrophils and erythrocytes is taken by discarding the 
supernatant layer containing lymphocytes, monocytes and plasma layer on top 
respectively. 
 Sediment is mixed with equal volume of 6% (room temperature) dextran (in Normal 
Saline) and incubated at 37°C for 45 minutes to allow the sedimentation of 
erythrocytes. 
 Pellet containing erythrocytes is discarded and the neutrophils rich supernatant is 
collected and mixed with 10ml of PBS. 
 Reaction mixture is centrifuged at 290xg for 10 minutes at 4°C, 1500rpm. 
 The pellet containing the neutrophils was taken by removing the supernatant. 
 Washing with 1ml PBS, repeat once or twice depending on the amount of 
erythrocytes present as a contaminant. 
 The supernatant was removed by taking the pellet. 
 Resuspend pellet in 1.2ml RPMI, Aliquot 200ul into eppi to perform a cell count. 
(Use the cell dyne)   
 The final neutrophils pellet was resuspended into desired volume of media (RMPI) to 
achieve the appropriate cell concentration usually 1x10-6 cells/ ml.  
 Spin down for 10 minutes at 4°C, 1500rpm. 
 Remove supernatant and resuspend pellet in PBS (eg. If the cell down gave a count of 
2.7x10-6 cells/ ml and we want 1x10-6 cells/ ml the resuspend pellet in 270ul of PBS). 
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 Defrost Paraformaldehyde. 
 Depending on the amount of stains you need to do, try aliquot 100ul with 1x10-6 cells/ 
ml into two eppi’s (multiple stained and the unstained) 
 Switch light off in the hood once you start staining. Add 20ul surface marker antibody 
CD66b to the multiple stained eppi and 20ul PBS in the unstained eppi. 
 Vortex gently 
 Leave in fridge for 30min at 4°C covered in tinfoil 
 Add 500ul PBS 
 Vortex gently 
 Centrifuge at 1800rmp for 6min  
 Remove supernatant and resuspend in 250ul cytofix/cytoperm 
 Mix gently 
 Leave in fridge for 25min at 4°C covered in tinfoil. 
 Add 500ul BD perm wash 
 Vortex gently 
 Centrifuge at 1800rpm for 6min 
 Remove supernatant 
 Add intracellular markers 5ul ICAM and 5ul VCAM to the multiple stain, add 10ul 
PBS to the unstained. 
 Leave in fridge for 30min at 4°C covered in tinfoil 
 Repeat wash with 250ul BD perm wash 
 Vortex gently 
 Centrifuge at 1800rpm for 6min 
 Remove supernatant 
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 Resuspend in 500ul 4% paraformaldehyde. 
 Leave in fridge at 4°C overnight, covered in foil 
 Perform flow cytometry analysis in the morning 
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Addendum D: SOP NEUTROPHIL ISOLATION FOR 8 CHAMBER 
SLIDE/WELL  
 
 2ml Histopaque1077(room temperature) is pipette into a 15ml falcon tube and then 
double volume (4ml) of anticoagulant added blood was carefully poured on this 
Histopaque layer down the side of each tube. 
 Tubes are transferred to the centrifuge machine with swinging rotar and are spun at 
speed of 652xg for 30 minutes at 21°C, 1800rpm. 
* Four different layers of blood are formed* 
 Sediment containing neutrophils and erythrocytes is taken by discarding the 
supernatant layer containing lymphocytes, monocytes and plasma layer on top 
respectively. 
 Sediment is mixed with equal volume of 6% (room temperature) dextran (in Normal 
Saline) and incubated at 37°C for 45 minutes to allow the sedimentation of 
erythrocytes. 
 8 well plate needs to be activated, 30min open under a UV light. 
 Pellet containing erythrocytes is discarded and the neutrophils rich supernatant is 
collected and mixed with 10ml of PBS. 
 Reaction mixture is centrifuged at 290xg for 10 minutes at 4°C, 1500rpm. 
 The pellet containing the neutrophils was taken by removing the supernatant. 
 Washing with 1ml PBS, repeat once or twice depending on the amount of 
erythrocytes present as a contaminant. 
 The supernatant was removed by taking the pellet. 
 Resuspend pellet in 1.2ml RPMI, Aliquot 200ul into eppi to perform a cell count. 
(Use the cell dyne)   
 The final neutrophils pellet was resuspended into desired volume of media (RMPI) to 
achieve the appropriate cell concentration usually 1x10-6 cells/ ml.  
 Add 75ul to the bottom left hand corner of each well in the 8 well plate. 
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 Take 8 well plate to the Olympus microscope and mount the 8 well plate. 
 
 Add Fmlp to the opposite (top right hand corner) this will allow for chemotaxis to 
take place while a video can be made tracking the neutrophils movements. (If 
comparing a chemoattractant to a control, replace the Fmlp with RPMI). 
 Track neutrophils for 45min on Olympus microscope. 
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Addendum E: SOP FOR IMMUNOHISTOCHEMISTRY 
 
 Fix cells in 4% paraformaldehyde (75ul and 75ul RPMI) in each well, incubate for 
10min at 37°C. 
 Wash with 100ul PBS x3 per well 
 Permeabilized with 0.1% Triton X-100 for 5min 
 Wash with 200ul PBS, leave for 5min 
 Block with 150ul 1% BSA, leave for 20min 
 Add Primary conjugated antibody (100ul in total). Leave in fridge at 4°C covered in 
tinfoil overnight. 
 Anti-ROCK (488) dilution 1:50 (10ul in 500ul PBS) 
 Anti-PI3K (647) dilution 1:70 (7.1ul in 500ul PBS) 
 Wash with cold PBS x 3 
 Add 100ul DAPPI for 10min 
 Wash with cold PBS x3 
 Leave 100ul PBS in each well for Visualization 
 Visualize with confocal microscope. 
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Addendum F: PARTICIPANT INFORMATION LEAFLET  
 
 
TITLE OF THE RESEARCH PROJECT:   
 
REFERENCE NUMBER: 
 
PRINCIPAL INVESTIGATOR: Tanya Smith 
 
ADDRESS: Dept Physiological Sciences, Stellenbosch University, Private Bag X1, 
Matieland, 7602 OR Dept Physiological Sciences, Room 2014, Mike de Vries building, 
Merriman Avenue, Main Campus, Stellenbosch 
CONTACT NUMBER: 0733766440 
Dear Colleague (fellow student, etc) 
My name is Tanya Smith and I am a master’s student and I would like to invite you to 
participate in a research project that aims to investigate changes in experimentally induced 
chemokinetic responses after in vivo supplementation with grape seed-derived 
proanthocyanidolic oligomers (PCO). 
Please take some time to read the information presented here, which will explain the details 
of this project and contact me if you require further explanation or clarification of any aspect 
of the study. Also, your participation is entirely voluntary and you are free to decline to 
participate.  If you say no, this will not affect you negatively in any way whatsoever.  You are 
also free to withdraw from the study at any point, even if you do agree to take part. 
This study has been approved by the Health Research Ethics Committee (HREC) at 
Stellenbosch University and will be conducted according to accepted and applicable National 
and International ethical guidelines and principles, including those of the international 
Declaration of Helsinki October 2008.  
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Description of the study: 
Since the study is designed to be largely in vitro, all participants will be required to follow the 
subject requirements.  We will obtain a resting blood sample (5ml blood anti-coagulated in 
sodium heparin and 5ml EDTA, as well as 5ml sodium citrate) from individuals prior to the 
two week study. Baseline parameters for each individual will be determined. The participants 
will then be placed on either the placebo or PCO supplement for two weeks. A second blood 
sample will be taken after 7 days to monitor full blood count and clotting profile only.  The 
last blood sample will be taking at the end of the two week study.  All blood will be drawn by 
an experienced phlebotomist from a forearm vein. 
Clotting profile:  A full blood count will be done.  
We will be looking at neutrophil migration patterns using live cell tracking and 
immunofluorescence staining. As well as the role of adhesion molecules and the impact of 
macrophages via low cytometry.  
 
Study population 
We will recruit both male and female individuals between 18-25 years of age.  For 
recruitment, we will invite volunteers by advertisements on notice boards on campus.  Refer 
to appendix A for an example of such an advertisement.  Ideally, a total of 20 individuals will 
complete the protocol. 
Inclusion criteria would be any person that are normally healthy, not on any other type of 
supplements, recreationally active and non-smoking. Exclusion criteria: Individuals with 
known inflammatory disease, or chronic disease or known to have any sort of inflammatory 
component such as sinus or hayfever suffers, will be excluded from the study.  Subjects will 
be required to refrain from taking vitamin or anti-oxidant supplements for a period of 14 days 
prior to initiation of the protocol, as well as for the duration of the entire protocol. All 
subjects will be required to refrain from exercise for a period of 24 hours prior to each sample 
collection time point 
Anticipated benefits, risks and precautions 
PCO could prove to be a cost-effective way of modulating inflammation beneficially.  
Participants will be informed at the end of the study whether they received the real 
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supplement or placebo and will be given the option to take a free 2-week supply of the 
product, if we have shown it to have beneficial effects as anticipated. 
 
The normal, minimal risk of bruising and infection associated with blood draws will exist, but 
since experienced phlebotomists will be taking blood samples, we are confident that we have 
minimised this risk.  In addition, since blood clotting has adhesion molecule involvement, 
there is theoretically a small risk of mild hypo-coagulability. Although no anecdotal reports 
of bleeding episodes have been received from users of this product or participants in previous 
studies by our group, we will monitor clotting profiles weekly. 
Ethical considerations 
We are confident that we have optimised subject number to ensure sufficient statistical 
power, while limiting subject number. In order to maintain confidentiality, all samples will be 
labelled using code known only to the principal and sub-investigator. 
We have the necessary human resources, infrastructure and expertise in place to perform this 
study. We are confident that the anticipated benefits from this study outweighs the minor 
risks by far. 
 
 
If you are willing to participate in this study please sign the attached Declaration of Consent 
and (hand it to the investigator) 
 
Yours sincerely 
 
Tanya Smith 
 
Principal Investigator 
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Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled ……….. 
 . 
 
I declare that: 
 
 I have read the attached information leaflet and it is written in a language with which I 
am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been pressurised 
to take part. 
 I may choose to leave the study at any time and will not be penalised or prejudiced in 
any way. 
 I may be asked to leave the study before it has finished, if the researcher feels it is in 
my best interests, or if I do not follow the study plan, as agreed to. 
 
 
Signed at (place) ......................…........…………….. On (date) …………....……….. 2015. 
 
 
Signature of participant  
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Addendum G: PARTICIPANT INFORMATION LEAFLET AND 
CONSENT FORM 
 
 
TITLE OF THE RESEARCH PROJECT: Assessment of in vitro inflammatory responses 
after in vivo supplementation with grape seed-derived proanthocyanidolic oligomers (PCO). 
 
 
REFERENCE NUMBER: 
 
PRINCIPAL INVESTIGATOR: Tanya Smith 
 
ADDRESS: Dept Physiological Sciences, Stellenbosch University, Private Bag X1, 
Matieland, 7602 OR Dept Physiological Sciences, Room 2014, Mike de Vries building, 
Merriman Avenue, Main Campus, Stellenbosch 
 
 
 
CONTACT NUMBER: 0733766440 
 
 
You are being invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the 
study staff or doctor any questions about any part of this project that you do not fully 
understand.  It is very important that you are fully satisfied that you clearly understand what 
this research entails and how you could be involved.  Also, your participation is entirely 
voluntary and you are free to decline to participate.  If you say no, this will not affect you 
negatively in any way whatsoever.  You are also free to withdraw from the study at any point, 
even if you do agree to take part. 
 
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice 
and the Medical Research Council (MRC) Ethical Guidelines for Research. 
 
 
What is this research study all about? 
The study will be of longitudinal, placebo-controlled design and will be performed in the 
tissue culture and human physiology laboratories of the Department Physiological Sciences at 
Stellenbosch University. We will recruit both male and female individuals between 18-25 
years of age. Ideally, a total of 20 individuals will complete the protocol. Given these 
promising effects we have been able to illustrate in the context of PCO treatment during 
previous studies done by our group, we would like to investigate potential mechanisms by 
which these anti-inflammatory effects are achieved. We propose to assess the potential of 
grape seed-derived PCO in this context. 
Since the modulation of inflammation is not only relevant to individuals in the sporting arena 
or aged individuals, but also to the aetiology and thus treatment of various chronic disease 
states, this study is of high relevance to our society as a whole. Inclusion criteria would be 
any person that are normally healthy, not on any other type of supplements, recreationally 
active and non-smoking.  
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Sample collection: Since the study is designed to be largely in vitro, all participants will be 
required to follow the subject requirements.  We will obtain a resting blood sample (5ml 
blood anti-coagulated in sodium heparin and 5ml EDTA, as well as 5ml sodium citrate) from 
individuals prior to the two week study. Baseline parameters for each individual will be 
determined. The participants will then be placed on either the placebo or PCO supplement for 
two weeks. A second blood sample will be taken after 7 days to monitor full blood count and 
clotting profile only.  The last blood sample will be taken at the end of the supplementation 
period.  All blood will be drawn by an experienced phlebotomist from a forearm vein. 
Sample analysis 
Full blood count: A full blood count will be performed on EDTA blood in the dept 
Physiological Sciences using an automated cell counter (Celldyne 3700 CS) and general 
haematology and immunology profile will be assessed by experienced medical technologist 
registered with the HPSCA (Prof C Smith).   
The citrate blood will be analysed for clotting profile by PathCare Stellenbosch, using 
standard laboratory practise. 
   
 
  
 
Why have you been invited to participate? 
You are between the age 18-25, you are not on any supplements, you do not smoke and you 
do not suffer from inflammatory disease or chronic disease linked to an inflammatory 
component such as sinus/ hayfever suffers. 
 
 
What will your responsibilities be? 
Subjects will be required to refrain from taking vitamin or anti-oxidant supplements as well 
as any strenuous exercise for a period of 14 days prior to initiation of the protocol, as well as 
for the duration of the entire protocol. All subjects will be required to refrain from exercise 
for a period of 24 hours prior to each sample collection time point. 
 
 
 
Will you benefit from taking part in this research? 
PCO could prove to be a cost-effective way of modulating inflammation beneficially.  
Participants will be informed at the end of the study whether they received the real 
supplement or placebo and will be given the option to take a free 2-week supply of the 
product, if we have shown it to have beneficial effects as anticipated. However participants 
might not experience the full benefit as the duration period might be a factor, but future 
participants will. 
 
 
Are there in risks involved in your taking part in this research? 
The normal, minimal risk of bruising and infection associated with blood draws will exist, but 
since experienced phlebotomists will be taking blood samples, we are confident that we have 
minimised this risk.  In addition, since blood clotting has adhesion molecule involvement, 
there is theoretically a small risk of mild hypocoagulability in PCO-supplemented 
individuals. Although no anecdotal reports of bleeding episodes have been received from 
users of this product or participants in previous studies by our group, we will monitor clotting 
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profiles weekly. In the unlikely event of a participant exhibiting abnormal clotting times, 
supplementation will be discontinued straight away. 
 
 
If you do not agree to take part, what alternatives do you have? 
There is no alternative protocol. 
 
Who will have access to your medical records? 
In order to maintain confidentiality, all samples will be labelled using code known only to the 
principal and sub-investigator, but we will not have access to your medical records. 
 
What will happen in the unlikely event of some form injury occurring as a direct result 
of your taking part in this research study? 
In the unlikely event of some form of injury occurring a departmental investigation will be 
done and necessary steps shall be taken keeping into consideration the participants best 
interests.  
 
Will you be paid to take part in this study and are there any costs involved? 
 
No you will not be paid to take part in the study but your transport and meal costs will be 
covered for each study visit.  There will be no costs involved for you, if you do take part. 
 
 
Is there anything else that you should know or do? 
 You can contact Dr Carine Smith at tel 021-808 3146 if you have any further queries 
or encounter any problems. 
 You can contact the Health Research Ethics Committee at 021-938 9207 if you have 
any concerns or complaints that have not been adequately addressed by your study 
doctor. 
 You will receive a copy of this information and consent form for your own records. 
 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled (insert title of study). 
 
I declare that: 
 
 I have read or had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been adequately 
answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
Stellenbosch University  https://scholar.sun.ac.za
 102 
 I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as 
agreed to. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2015. 
 
 
 
......................................................................   ...................................................................  
Signature of participant Signature of witness 
 
 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
 I did/did not use a interpreter.  (If a interpreter is used then the interpreter must 
sign the declaration below. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2015. 
 
 
 
......................................................................   ...................................................................  
Signature of investigator Signature of witness 
 
 
Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
 I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
 We encouraged him/her to ask questions and took adequate time to answer them. 
 I conveyed a factually correct version of what was related to me. 
 I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
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Signed at (place) ......................…........…………….. on (date) …………....……………….. 
 
 
 
......................................................................   ...................................................................  
Signature of interpreter Signature of witness 
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Addendum H: FLYER FOR RECRUITMENT 
ATTENTION: SCIENCE NEEDS YOUR HELP!! 
 Are you between the ages of 18-25  
 Are you willing to donate 3 small blood samples to further our understanding of 
inflammation?  
 Are you not on any types of supplements? 
 Are you willing to take a commercially available natural product supplement for 2 
weeks? 
If you answered “YES” to the above questions, you have the opportunity to be part of a 
health solution! 
If you would like to participate in a research study, please contact Tanya Smith, 
16055683@sun.ac.za or on 0733766440 
Thank you – we are waiting for your call!!  
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Addendum I: ETHICS APPROVAL 
 
21-Jan-2016 
Smith, Tanya T 
Ethics Reference #: M15/09/040 
Approved with Stipulations 
Response to Modifications- (New Application) 
Title: Assessment of in vitro inflammatory responses after in vivo supplementation with 
grape seed-derived 
Dear Miss Tanya Smith, proanthocyanidolic oligomers (PCO). 
The Response to Modifications - (New Application) received on 10-Dec-2015, was reviewed 
by members of Health Research Ethics Committee 1 via Expedited review procedures on 08-
Jan-2016. 
Please note the following information about your approved research protocol: 
Protocol Approval Period: 21-Jan-2016 -20-Jan-2017 
The Stipulations of your ethics approval are as follows: 
GCP certificates for PI still needs to be submitted 
Please remember to use your protocol number (M15/09/040) on any documents or 
correspondence with the HREC concerning your research protocol. 
Please note that the HREC has the prerogative and authority to ask further questions, seek 
additional information, require further modifications, or monitor the conduct of your research 
and the consent process. 
After Ethical Review: 
Please note a template of the progress report is obtainable on www.sun.ac.za/rds and should 
be submitted to the Committee before the year has expired. 
The Committee will then consider the continuation of the project for a further year (if 
necessary). Annually a number of projects may be selected randomly for an external audit. 
Translation of the consent document to the language applicable to the study participants 
should be submitted. 
Federal Wide Assurance Number: 00001372 
Institutional Review Board (IRB) Number: IRB0005239 
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The Health Research Ethics Committee complies with the SA National Health Act No.61 
2003 as it pertains to health research and the United States 
Code of Federal Regulations Title 45 Part 46. This committee abides by the ethical norms and 
principles for research, established by the Declaration of 
Helsinki, the South African Medical Research Council Guidelines as well as the Guidelines 
for Ethical Research: Principles Structures and Processes 
Provincial and City of Cape Town Approval 
Please note that for research at a primary or secondary healthcare facility permission must 
still be obtained from the relevant authorities (Western Cape 
Department of Health and/or City Health) to conduct the research as stated in the protocol. 
Contact persons are Ms Claudette Abrahams at Western 
Cape Department of Health (healthres@pgwc.gov.za Tel: +27 21 483 9907) and Dr Helene 
Visser at City Health (Helene.Visser@capetown.gov.za Tel: 
+27 21 400 3981). Research that will be conducted at any tertiary academic institution 
requires approval from the relevant hospital manager. Ethics 
Approval is required BEFORE approval can be obtained from these health authorities. 
We wish you the best as you conduct your research. 
For standard HREC forms and documents please visit: www.sun.ac.za/rds 
If you have any questions or need further assistance, please contact the HREC office at 
0219389657. 
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Included Documents: 
Description of study site 
ICF English 
Cover Letter 
Flow Chart 
20151211 Mods Req - ICF clean copy 
Supervisor CV - C Smith 
Protocol 
Package Insert 
Protocol Synopsis 
GCP letter - T Smith 
Flyer for recruitment 
20151210 Mods Req - Response letter 
MCC letter 
Certificate of Insurance 
Investigator CV - T Smith 
Investigator Declaration - C Smith 
Investigator Declaration - T Smith 
Application Form 
Clinical Trials Checklist 
NHREC Trial Application 
20151210 Mods Req - Consent Form 
Sincerely, 
Franklin Weber 
HREC Coordinator 
Health Research Ethics Committee 12004 (Department of Health). 
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Investigator Responsibilities 
Protection of Human Research Participants 
Some of the responsibilities investigators have when conducting research involving human 
participants are listed below:  
1.Conducting the Research. You are responsible for making sure that the research is 
conducted according to the HREC approved research protocol. You are also responsible for 
the actions of all your co-investigators and research staff involved with this research.  
2.Participant Enrolment. You may not recruit or enrol participants prior to the HREC 
approval date or after the expiration date of HREC approval. All recruitment materials for 
any form of media must be approved by the HREC prior to their use. If you need to recruit 
more participants than was noted in your HREC approval letter, you must submit an 
amendment requesting an increase in the number of participants.  
3.Informed Consent. You are responsible for obtaining and documenting effective informed 
consent using only the HREC-approved consent documents, and for ensuring that no human 
participants are involved in research prior to obtaining their informed consent. Please give all 
participants copies of the signed informed consent documents. Keep the originals in your 
secured research files for at least fifteen (15) years.  
4.Continuing Review. The HREC must review and approve all HREC-approved research 
protocols at intervals appropriate to the degree of risk but not less than once per year. There is 
no grace period. Prior to the date on which the HREC approval of the research expires, it is 
your responsibility to submit the continuing review report in a timely fashion to ensure 
a lapse in HREC approval does not occur. If HREC approval of your research lapses, you 
must stop new participant enrolment, and contact the HREC office immediately.  
5.Amendments and Changes. If you wish to amend or change any aspect of your research 
(such as research design, interventions or procedures, number of participants, participant 
population, informed consent document, instruments, surveys or recruiting material), you 
must submit the amendment to the HREC for review using the current Amendment Form. 
You may not initiate any amendments or changes to your research without first obtaining 
written HREC review and approval. The only exception is when it is necessary to eliminate 
apparent immediate hazards to participants and the HREC should be immediately informed of 
this necessity.  
6.Adverse or Unanticipated Events. Any serious adverse events, participant complaints, and 
all unanticipated problems that involve risks to participants or others, as well as any research-
related injuries, occurring at this institution or at other performance sites must be reported to 
the HREC within five (5) days of discovery of the incident. You must also report any 
instances of serious or continuing problems, or non-compliance with the HRECs 
requirements for protecting human research participants. The only exception to this policy is 
that the death of a research participant must be reported inaccordance with the Stellenbosch 
Universtiy Health Research Ethics Committee Standard Operating Procedures  
www.sun025.sun.ac.za/portal/page/portal/Health_Sciences/English/Centres%20and%20Instit
utions/Research_Development_Support/Ethics/Application_package All reportable events 
should be submitted to the HREC using the Serious Adverse Event Report Form. 
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7.Research Record Keeping. You must keep the following research-related records, at a 
minimum, in a secure location for a minimum of fifteen years: the HREC approved research 
protocol and all amendments; all informed consent documents; recruiting materials; 
continuing review reports; adverse or unanticipated events; and all correspondence from the 
HREC 
8.Reports to the MCC and Sponsor. When you submit the required annual report to the MCC 
or you submit required reports to your sponsor, youmust provide a copy of that report to the 
HREC. You may submit the report at the time of continuing HREC review. 
9.Provision of Emergency Medical Care. When a physician provides emergency medical care 
to a participant without prior HREC review and approval,to the extent permitted by law, such 
activities will not be recognised as research nor will the data obtained by any such activities 
should it be used insupport of research. 
10.Final reports. When you have completed (no further participant enrolment, interactions, 
interventions or data analysis) or stopped work on yourresearch, you must submit a Final 
Report to the HREC. 
11.On-Site Evaluations, MCC Inspections, or Audits. If you are notified that your research 
will be reviewed or audited by the MCC, the sponsor, anyother external agency or any 
internal group, you must inform the HREC immediately of the impending audit/evaluation. 
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